<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/otolaryngology_oapdeposits/rss"/>
    <ttl>720</ttl>
    <title>Recent otolaryngology_oapdeposits items</title>
    <link>https://escholarship.org/uc/otolaryngology_oapdeposits/rss</link>
    <description>Recent eScholarship items from Open Access Policy Deposits</description>
    <pubDate>Sat, 13 Jun 2026 00:28:36 +0000</pubDate>
    <item>
      <title>Smad7-based biologic targeting epidermis and stroma promotes healing of diabetic wounds in mice and pigs</title>
      <link>https://escholarship.org/uc/item/7f75g7xt</link>
      <description>Diabetic wounds have limited effective therapies to restore tissue repair and resolve excessive inflammation. This study aimed to identify mechanisms of diabetic wound healing defects and test a therapeutic intervention using diabetic mouse and pig models. Here, we show that Smad7 transgene expression in mouse epidermis promotes wound healing in diabetic mice. To restrict the therapeutic effects of Smad7 on wounds, we develop a Smad7-based biologic (Tat-PYC-Smad7) that penetrates cells of the wound. Topical Tat-PYC-Smad7 treatment to diabetic pig and mouse wounds accelerates healing. Tat-PYC-Smad7-treated wounds exhibit reduced TGFβ/NFκB signaling, faster re-epithelialization, and better extracellular matrix remodeling compared to vehicle controls. Tat-PYC-Smad7 also attenuates neutrophil extracellular trap (NET) formation, potentially acting through reductions in MPO enzymatic activity and MPO nuclear entry, consequently reducing chromatin decondensation and the release of NET...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7f75g7xt</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ke, Yao</name>
      </author>
      <author>
        <name>Li, Ben-Zheng</name>
      </author>
      <author>
        <name>Li, Fulun</name>
      </author>
      <author>
        <name>Ravindran, Resmi</name>
      </author>
      <author>
        <name>Wang, Donna</name>
      </author>
      <author>
        <name>Wang, Suyan</name>
      </author>
      <author>
        <name>Hwang, Samuel T</name>
      </author>
      <author>
        <name>Simon, Scott I</name>
      </author>
      <author>
        <name>Collins, Sean R</name>
        <uri>https://orcid.org/0000-0002-4276-5840</uri>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Should Antithrombotic Therapy Be Withheld Perioperatively for Cutaneous Facial Reconstructions?</title>
      <link>https://escholarship.org/uc/item/01t5g2sz</link>
      <description>Should Antithrombotic Therapy Be Withheld Perioperatively for Cutaneous Facial Reconstructions?</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/01t5g2sz</guid>
      <pubDate>Wed, 8 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Roy, Catherine F</name>
      </author>
      <author>
        <name>Magro, Isabelle L</name>
        <uri>https://orcid.org/0000-0001-6002-3843</uri>
      </author>
      <author>
        <name>Tollefson, Travis T</name>
        <uri>https://orcid.org/0000-0002-8658-8647</uri>
      </author>
      <author>
        <name>Shaye, David A</name>
        <uri>https://orcid.org/0000-0002-7786-7812</uri>
      </author>
    </item>
    <item>
      <title>Distinct core thalamocortical pathways to central and dorsal primary auditory cortex</title>
      <link>https://escholarship.org/uc/item/9v05g350</link>
      <description>The cat primary auditory cortex (AI) is usually assumed to form one continuous functional region. However, the dorsal and central parts of the AI iso-frequency domain contain neurons that have distinct response properties to acoustic stimuli. In this study, we asked whether neurons projecting to dorsal versus central regions of AI originate in different parts of the medial geniculate body (MGB). Spike rate responses to variations in the sound level and frequency of pure tones were used to measure characteristic frequency (CF) and frequency resolution. These were mapped with high spatial density in order to place retrograde tracers into matching frequency regions of the central narrow-band region (cNB) and dorsal AI. Labeled neurons projecting to these two parts of AI were concentrated in the middle and rostral thirds of the MGB, respectively. There was little evidence that differences in dorsal and central AI function could be due to convergent input from cells outside the ventral...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9v05g350</guid>
      <pubDate>Thu, 15 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Read, Heather L</name>
      </author>
      <author>
        <name>Nauen, David W</name>
      </author>
      <author>
        <name>Escabí, Monty A</name>
      </author>
      <author>
        <name>Miller, Lee M</name>
      </author>
      <author>
        <name>Schreiner, Christoph E</name>
        <uri>https://orcid.org/0000-0002-4571-4328</uri>
      </author>
      <author>
        <name>Winer, Jeffery A</name>
      </author>
    </item>
    <item>
      <title>The Contribution of Spike Threshold to Acoustic Feature Selectivity, Spike Information Content, and Information Throughput</title>
      <link>https://escholarship.org/uc/item/93s8r53j</link>
      <description>Hypotheses of sensory coding range from the notion of nonlinear "feature detectors" to linear rate coding strategies. Here, we report that auditory neurons exhibit a novel trade-off in the relationship between sound selectivity and the information that can be communicated to a postsynaptic cell. Recordings from the cat inferior colliculus show that neurons with the lowest spike rates reliably signal the occurrence of stereotyped stimulus features, whereas those with high response rates exhibit lower selectivity. The highest information conveyed by individual action potentials comes from neurons with low spike rate and high selectivity. Surprisingly, spike information is inversely related to spike rates, following a trend similar to that of feature selectivity. Information per time interval, however, was proportional to measured spike rates. A neuronal model based on the spike threshold of the synaptic drive accurately accounts for this trade-off: higher thresholds enhance the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/93s8r53j</guid>
      <pubDate>Thu, 15 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Escabí, Monty A</name>
      </author>
      <author>
        <name>Nassiri, Reza</name>
      </author>
      <author>
        <name>Miller, Lee M</name>
      </author>
      <author>
        <name>Schreiner, Christoph E</name>
        <uri>https://orcid.org/0000-0002-4571-4328</uri>
      </author>
      <author>
        <name>Read, Heather L</name>
      </author>
    </item>
    <item>
      <title>Two thalamic pathways to primary auditory cortex</title>
      <link>https://escholarship.org/uc/item/0h3060g8</link>
      <description>Neurons in the center of cat primary auditory cortex (AI) respond to a narrow range of sound frequencies and the preferred frequencies in local neuron clusters are closely aligned in this central narrow bandwidth region (cNB). Response preferences to other input parameters, such as sound intensity and binaural interaction, vary within cNB; however, the source of this variability is unknown. Here we examined whether input to the cNB could arise from multiple, anatomically independent subregions in the ventral nucleus of the medial geniculate body (MGBv). Retrograde tracers injected into cNB labeled discontinuous clusters of neurons in the superior (sMGBv) and inferior (iMGBv) halves of the MGBv. Most labeled neurons were in the sMGBv and their density was greater, iMGBv somata were significantly larger. These findings suggest that cNB projection neurons in superior and iMGBv have distinct anatomic and possibly physiologic organization.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0h3060g8</guid>
      <pubDate>Thu, 15 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Read, HL</name>
      </author>
      <author>
        <name>Miller, LM</name>
      </author>
      <author>
        <name>Schreiner, CE</name>
        <uri>https://orcid.org/0000-0002-4571-4328</uri>
      </author>
      <author>
        <name>Winer, JA</name>
      </author>
    </item>
    <item>
      <title>Spatial Transcriptomic Landscape of Canine Oral Squamous Cell Carcinoma</title>
      <link>https://escholarship.org/uc/item/5db0929d</link>
      <description>Canine oral squamous cell carcinoma (COSCC) is the second most common oral tumor in dogs and the most relevant for comparative human trials as a spontaneous large animal model of disease. Historical genomic work has focused primarily on bulk sequencing. The present study describes the complete transcriptomic landscape of COSCC with spatial distinction between the surface tumor, deep invasive tumor, peritumoral dysplastic epithelium, and tumor microenvironment compared to matched normal oral samples. Each region demonstrated distinct molecular signatures. Genes related to epithelial growth factor (EGFR) and epithelial-mesenchymal transformation (EMT) were upregulated in both peritumoral dysplasia and surface cancer. Additionally, the KRAS gene set, KRT17, and SSP1 were enriched in cancer. We identified five genes that represent dysplastic lesion with high potential for malignant transformation (FZD4, GAS1, HACD2, NOG, and SLC39A6). Also, three genes, SFRP4, FZD1, and IL34 represented...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5db0929d</guid>
      <pubDate>Tue, 22 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Goldschmidt, Stephanie</name>
        <uri>https://orcid.org/0000-0001-5944-4202</uri>
      </author>
      <author>
        <name>Tepper, Clifford G</name>
      </author>
      <author>
        <name>Goon, Jack</name>
      </author>
      <author>
        <name>Soltero‐Rivera, Maria</name>
      </author>
      <author>
        <name>Rebhun, Robert</name>
        <uri>https://orcid.org/0000-0002-8047-3494</uri>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Wang, Xiao‐Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Davis, Ryan R</name>
        <uri>https://orcid.org/0000-0001-7439-6683</uri>
      </author>
      <author>
        <name>Liu, Stephenie Y</name>
      </author>
      <author>
        <name>Rivas, Iris</name>
      </author>
      <author>
        <name>Murphy, Brian</name>
        <uri>https://orcid.org/0000-0003-0057-0604</uri>
      </author>
      <author>
        <name>Vapniarsky, Natalia</name>
      </author>
    </item>
    <item>
      <title>A practical and safer model of nitrogen mustard injury in cornea</title>
      <link>https://escholarship.org/uc/item/4p48n5w0</link>
      <description>PURPOSE: Sulfur mustard (SM) is an alkylating agent used in warfare and terrorism that inflicts devastating ocular injuries. Although the clinical symptoms are well described, the underlying mechanisms are not fully understood, hindering the development of effective treatments. One major roadblock is the lack of a suitable model due to the extremely hazardous nature of SM, which requires strict safety measures. As a safer and practical alternative, we report a novel model that uses mechlorethamine (nitrogen mustard) gel, an FDA-approved topical chemotherapeutic administered by patients at home. Here we demonstrate its suitability to induce mustard corneal injury in any laboratory.
METHODS: Ex vivo porcine corneas were injured with mechlorethamine gel. Hematoxylin-eosin staining and immunohistochemistry were performed to evaluate histopathology of SM-like corneal injuries: epithelium thickness and stromal separation, keratocyte and inflammatory cell counts, and expression of inflammation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4p48n5w0</guid>
      <pubDate>Fri, 11 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Sandoval-Castellanos, Ana M</name>
      </author>
      <author>
        <name>Ke, Yao</name>
      </author>
      <author>
        <name>Dam, Tiffany M</name>
      </author>
      <author>
        <name>Maverakis, Emanual Michael</name>
        <uri>https://orcid.org/0000-0002-6294-6294</uri>
      </author>
      <author>
        <name>Mannis, Mark J</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Zhao, Min</name>
        <uri>https://orcid.org/0000-0002-2500-3035</uri>
      </author>
    </item>
    <item>
      <title>Predictors of Donor‐Site Wound Complications Following Fibula Free Flap Reconstruction</title>
      <link>https://escholarship.org/uc/item/0zr2w2jr</link>
      <description>Objective: The fibula free flap (FFF) remains the workhorse flap for head and neck defects necessitating osteocutaneous reconstruction. Although lower extremity angiography, ultrasound (US), and other vascular studies are routinely used for fibula assessment and patient selection, predictors of donor-site morbidity following harvest remain poorly understood. We sought to investigate the factors associated with FFF donor-site complications.
Study Design: Retrospective analysis of patients at a tertiary care center.
Setting: Tertiary care center.
Methods: In total, 119 patients undergoing FFF reconstruction during the years 2012 to 2022 were included. Multivariable logistic regression was used to identify independent predictors of soft-tissue donor-site wound complications.
Results: A total of 48 (40.3%) patients developed a donor-site wound complication with an average time to diagnosis of 24 days (±16) following surgery. In multivariable regression, history of alcohol use disorder...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0zr2w2jr</guid>
      <pubDate>Fri, 6 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ershadifar, Soroush</name>
      </author>
      <author>
        <name>Colback, Angela</name>
      </author>
      <author>
        <name>Basmaci, Ugur Nur</name>
      </author>
      <author>
        <name>Wilson, Machelle</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Silverman, Dustin A</name>
      </author>
    </item>
    <item>
      <title>Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy</title>
      <link>https://escholarship.org/uc/item/98d1h9tj</link>
      <description>Cancer is a daunting global health problem with a steadily rising incidence. Despite the wide arsenal of current anticancer therapies, challenges such as drug resistance, tumor heterogeneity, poor targeting, and severe side effects often lead to suboptimal efficacy and poor patient outcomes, highlighting the&amp;nbsp;need for innovative therapies. Autophagy modulation has emerged as an attractive approach to complement existing therapies. The dual role of autophagy in cancer promotion and suppression has inspired the development of new drugs and therapeutic strategies focusing on both inhibition and induction. Despite the promising results of current autophagy modulators in preclinical studies, challenges such as the lack of selectivity and potency, toxicity, poor pharmacokinetics, and inadequate tumor targeting continue to limit their successful clinical translation. Many of these challenges could be overcome using nanomedicine. This review explores recent advancements in nanomedicine...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/98d1h9tj</guid>
      <pubDate>Wed, 7 May 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Mahri, Sohaib</name>
      </author>
      <author>
        <name>Villa, Rodolfo</name>
      </author>
      <author>
        <name>Shiau, Ya‐Ping</name>
      </author>
      <author>
        <name>Tang, Menghuan</name>
      </author>
      <author>
        <name>Racacho, Kelsey Jane</name>
      </author>
      <author>
        <name>Zong, Qiufang</name>
      </author>
      <author>
        <name>Chowdhury, Saiful Islam</name>
      </author>
      <author>
        <name>Hua, Tan</name>
      </author>
      <author>
        <name>Godinez, Felipe</name>
        <uri>https://orcid.org/0000-0002-0951-8370</uri>
      </author>
      <author>
        <name>Birkeland, Andrew</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Lin, Tzu‐Yin</name>
        <uri>https://orcid.org/0000-0001-6618-5157</uri>
      </author>
      <author>
        <name>Li, Yuanpei</name>
      </author>
    </item>
    <item>
      <title>Assessment of Patient Comprehension of Mohs Reconstruction Using Augmented Educational Materials in Preoperative Counselling</title>
      <link>https://escholarship.org/uc/item/5qs3c42z</link>
      <description>Assessment of Patient Comprehension of Mohs Reconstruction Using Augmented Educational Materials in Preoperative Counselling</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5qs3c42z</guid>
      <pubDate>Wed, 7 May 2025 00:00:00 +0000</pubDate>
      <author>
        <name>DeVictor, Sam</name>
      </author>
      <author>
        <name>Shehan, Jennifer N</name>
      </author>
      <author>
        <name>Swift, William M</name>
      </author>
      <author>
        <name>Lindeman, Nathan</name>
      </author>
      <author>
        <name>Funamura, Jamie L</name>
        <uri>https://orcid.org/0000-0002-0582-2826</uri>
      </author>
      <author>
        <name>Tollefson, Travis T</name>
        <uri>https://orcid.org/0000-0002-8658-8647</uri>
      </author>
    </item>
    <item>
      <title>Exploring a specific type of tissue-resident natural killer cell involved in the anti-tumor and immunotherapy response in human papillomavirus-positive head and neck squamous cell carcinoma using scRNA-seq</title>
      <link>https://escholarship.org/uc/item/3s5475np</link>
      <description>Background: Human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) is an increasingly common malignancy. We aimed to explore the immune heterogeneity of natural killer (NK) cells in HPV-positive HNSCC.
Methods: Single-cell RNA-sequencing (scRNA-seq) and bulk RNA-sequencing datasets of HPV-positive HNSCC data were obtained from the Gene Expression Omnibus (GEO) database. "Seurat", "harmony", and "SingleR" were used to perform the scRNA-seq analysis. Subsequently, the "cellphonedb" package was used for the cell crosstalk analysis, and the "clusterProfiler" package was used for the hallmark pathway enrichment analysis. Finally, the "gene set variation analysis" ("GSVA") package was used for the immune cell infiltration, Tumor Immune Dysfunction and Exclusion (TIDE), and risk-score analyses.
Results: A total of 30,562 cells were classified into 9 cell clusters that comprised 6 main cell types [i.e., T cells, natural killer T (NKT) cells, NK cells, B cells,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3s5475np</guid>
      <pubDate>Mon, 21 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lin, Wenrong</name>
      </author>
      <author>
        <name>Ding, Junwen</name>
      </author>
      <author>
        <name>Li, Qian</name>
      </author>
      <author>
        <name>Lin, Yuhao</name>
      </author>
      <author>
        <name>Ruan, Shenjiong</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Ding, Jianming</name>
      </author>
    </item>
    <item>
      <title>Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma</title>
      <link>https://escholarship.org/uc/item/9hn606g3</link>
      <description>Mucoepidermoid Carcinoma (MEC) is a common salivary malignant neoplasm. Approximately 60&amp;nbsp;% of MECs harbor translocations between CRTC1 or CRTC3 and MAML2, which are thought to drive disease pathogenesis. However, the precise structural mechanism driving this rearrangement remains uncharacterized. Here, we performed multi-omic and long read genomic sequencing, discovering a chain of alterations that created the CRTC1::MAML2 fusion, but also an unexpected MAML2 to MYBL1 rearrangement, suggesting that MYBL1 may play a larger role in salivary gland cancers than previously recognized. Furthermore, we discovered and validated recurrent TERT rearrangements and amplifications in MEC models. 5/5 MEC cell lines and 36/39 (92&amp;nbsp;%) primary MEC tumors harbored a TERT rearrangement or copy number amplification. Custom sequencing of the TERT locus confirmed translocation breakpoints in 13/33 (39&amp;nbsp;%) MECs, while exome sequencing confirmed frequent TERT amplifications. Critically,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9hn606g3</guid>
      <pubDate>Thu, 17 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gensterblum-Miller, Elizabeth</name>
      </author>
      <author>
        <name>Bhangale, Apurva</name>
      </author>
      <author>
        <name>Majid, Dana Al</name>
      </author>
      <author>
        <name>Pienkowski, Victor Murcia</name>
      </author>
      <author>
        <name>Rydzanicz, Malgorzata</name>
      </author>
      <author>
        <name>Janiszewska, Joanna</name>
      </author>
      <author>
        <name>Kostrzewska-Poczekaj, Magdalena</name>
      </author>
      <author>
        <name>Chang, Clifford</name>
      </author>
      <author>
        <name>Brummel, Collin</name>
      </author>
      <author>
        <name>Michmerhuizen, Nicole L</name>
      </author>
      <author>
        <name>Wang, Jiayu</name>
      </author>
      <author>
        <name>Sandford, Erin</name>
      </author>
      <author>
        <name>Tewari, Muneesh</name>
      </author>
      <author>
        <name>Wierzbicka, Malgorzata</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>McHugh, Jonathan B</name>
      </author>
      <author>
        <name>Spector, Matthew E</name>
      </author>
      <author>
        <name>Giefing, Maciej</name>
      </author>
      <author>
        <name>Jarmuz-Szymczak, Malgorzata</name>
      </author>
      <author>
        <name>Heft Neal, Molly E</name>
      </author>
      <author>
        <name>Brenner, J Chad</name>
      </author>
    </item>
    <item>
      <title>Idiopathic Subglottic Stenosis in Non‐Caucasian Women</title>
      <link>https://escholarship.org/uc/item/7fb1f6q1</link>
      <description>Objective: To characterize presentation, disease course, and treatment of idiopathic subglottic stenosis (iSGS) in non-Caucasian women and compare this cohort to the predominantly female, Caucasian patient cohorts identified in the literature.
Study Design: Retrospective review. Results are compared to systematic review of demographics.
Setting: Multiple California institutions from 2008 to 2021.
Methods: Patients with intubation within 2 years of disease or who met exclusion criteria listed in prior publications were excluded. A systematic review of iSGS patient demographics was also completed for comparison.
Results: Of 421 patients with iSGS, 58 self-identified as non-Caucasian women, with 50 ultimately included. Mean age of onset was 45.1 years old (95% confidence interval [CI], 41.5-48.8), and mean age at diagnosis was 47.2 years (95% CI, 43.6-50.7). Mean Charlson comorbidity index was 1.06 (n = 49, 95% CI, 0.69-1.44). At diagnosis, Cotton-Meyer severity scores (documented...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7fb1f6q1</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Suk, Amber</name>
      </author>
      <author>
        <name>Dehom, Salem</name>
      </author>
      <author>
        <name>Punjabi, Nihal</name>
      </author>
      <author>
        <name>Young, VyVy N</name>
      </author>
      <author>
        <name>Krishna, Priya D</name>
      </author>
      <author>
        <name>Reder, Lindsay</name>
      </author>
      <author>
        <name>O'Dell, Karla</name>
      </author>
      <author>
        <name>Gochman, Grant E</name>
      </author>
      <author>
        <name>Simmons, Ethan</name>
      </author>
      <author>
        <name>Verma, Sunil P</name>
      </author>
      <author>
        <name>Harmon, Matthew</name>
      </author>
      <author>
        <name>Weissbrod, Philip A</name>
      </author>
      <author>
        <name>Yang, Jin</name>
      </author>
      <author>
        <name>Tamares, Shanalee</name>
      </author>
      <author>
        <name>Crawley, Brianna K</name>
        <uri>https://orcid.org/0000-0003-1011-0433</uri>
      </author>
    </item>
    <item>
      <title>DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107</title>
      <link>https://escholarship.org/uc/item/5jq016p1</link>
      <description>Recurrent respiratory papillomatosis (RRP) is a chronic airway disease caused by Human Papillomavirus (HPV). INO-3107, DNA immunotherapy designed to elicit T-cells against HPV-6 and HPV-11, was evaluated in a 52-week Phase 1/2 study for efficacy, safety, and immunogenicity (NCT04398433). Thirty-two eligible adults with HPV-6 and/or HPV-11 RRP, requiring ≥2 surgical interventions in the year preceding dosing were enrolled between October 2020 and November 2021 and administered 4 INO-3107 doses by intramuscular injection followed by electroporation. The primary endpoint was safety and tolerability, as assessed by treatment-emergent adverse events (TEAEs). Secondary endpoints included surgical intervention frequency and change in RRP Severity Score (modified) post-INO-3107 and assessment of immune responses. 81% (26/32) of patients experienced surgery reduction following INO-3107 compared with the year prior to treatment. Blood assessments revealed HPV-6 and HPV-11 antigen-specific...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5jq016p1</guid>
      <pubDate>Wed, 2 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Morrow, Matthew P</name>
      </author>
      <author>
        <name>Gillespie, Elisabeth</name>
      </author>
      <author>
        <name>Sylvester, Albert</name>
      </author>
      <author>
        <name>Amin, Milan R</name>
      </author>
      <author>
        <name>Belafsky, Peter C</name>
      </author>
      <author>
        <name>Best, Simon R</name>
      </author>
      <author>
        <name>Friedman, Aaron D</name>
      </author>
      <author>
        <name>Klein, Adam M</name>
      </author>
      <author>
        <name>Lott, David G</name>
      </author>
      <author>
        <name>Mau, Ted</name>
      </author>
      <author>
        <name>Paniello, Randal C</name>
      </author>
      <author>
        <name>Pransky, Seth M</name>
      </author>
      <author>
        <name>Saba, Nabil F</name>
      </author>
      <author>
        <name>Tan, Grace S</name>
      </author>
      <author>
        <name>Wisotsky, Sadie</name>
      </author>
      <author>
        <name>Marcus, Sarah A</name>
      </author>
      <author>
        <name>Reuschel, Emma L</name>
      </author>
      <author>
        <name>Reed, Katherine S</name>
      </author>
      <author>
        <name>Weiner, David B</name>
      </author>
      <author>
        <name>Dallas, Michael</name>
      </author>
      <author>
        <name>Skolnik, Jeffrey M</name>
      </author>
    </item>
    <item>
      <title>Poor nutrition status associated with low patient satisfaction six months into treatment for head and neck/esophageal cancer treatment: A prospective multicenter cohort study</title>
      <link>https://escholarship.org/uc/item/5x43v6gb</link>
      <description>BACKGROUND: Patient-reported outcome measures have been associated with survival in oncology patients. Altered intake and malnutrition are common symptoms for patients treated for head and neck cancer and esophageal cancer (HNC/EC). The purpose of this study was to examine the relationship between patient-reported satisfaction with medical care and nutrition status.
METHODS: This prospective cohort study collected data from 11 international cancer care sites.
RESULTS: One hundred and sixtythree adult patients (n = 115 HNC; n = 48 EC) completed a patient satisfaction questionnaire (the Canadian Health Care Evaluation Project Lite) and were included. HNC/EC patient global satisfaction with medical care was 88.3/100 ± 15.3 at baseline and remained high at 86.6/100 ± 16.8 by 6 months (100 max satisfaction score). Poor nutrition status, as defined by the Patient-Generated Subjective Global Assessment Short Form, was associated with lower patient satisfaction with overall medical care,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5x43v6gb</guid>
      <pubDate>Tue, 1 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Widaman, Adrianne M</name>
      </author>
      <author>
        <name>Day, Andrew G</name>
      </author>
      <author>
        <name>Kuhn, Maggie A</name>
      </author>
      <author>
        <name>Dhaliwal, Rupinder</name>
      </author>
      <author>
        <name>Baracos, Vickie</name>
      </author>
      <author>
        <name>Findlay, Merran</name>
      </author>
      <author>
        <name>Bauer, Judith D</name>
      </author>
      <author>
        <name>de van der Schueren, Marian</name>
      </author>
      <author>
        <name>Laviano, Alessandro</name>
      </author>
      <author>
        <name>Martin, Lisa</name>
      </author>
      <author>
        <name>Gramlich, Leah</name>
      </author>
    </item>
    <item>
      <title>Clinical Management Update of Oral Leukoplakia: A Review From the American Head and Neck Society Cancer Prevention Service</title>
      <link>https://escholarship.org/uc/item/5mw337v9</link>
      <description>BACKGROUND: Oral potentially malignant disorders (OPMDs) occur in up to 4%-5% of the population, of which oral leukoplakia (OL) is the most common subtype. Predicting high-risk OL remains a challenge. Early diagnosis and effective treatment are thought to be of paramount importance to improve outcomes.
METHODS: We searched PubMed and Clinicaltrials.gov data for updates in the clinical management of OL from 2015 to current.
RESULTS: Recent publication of large cohorts of patients with OL aids in counseling patients regarding risk of malignant transformation. Management for OL includes surveillance, excision, and laser surgery, as well as local and systemic approaches to chemoprevention. Several new entities show promise regarding candidate biomarkers, chemoprevention agents, and diagnostic adjuncts, though all require further validation.
CONCLUSION: This update serves to further inform clinical management of OL and provide impetus for future investigations.
TRIAL REGISTRATION:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5mw337v9</guid>
      <pubDate>Mon, 20 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gates, James C</name>
      </author>
      <author>
        <name>Abouyared, Marianne</name>
      </author>
      <author>
        <name>Shnayder, Yelizaveta</name>
      </author>
      <author>
        <name>Farwell, D Gregory</name>
      </author>
      <author>
        <name>Day, Andrew</name>
      </author>
      <author>
        <name>Alawi, Faizan</name>
      </author>
      <author>
        <name>Moore, Michael</name>
      </author>
      <author>
        <name>Holcomb, Andrew J</name>
      </author>
      <author>
        <name>Birkeland, Andrew</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Epstein, Joel</name>
      </author>
    </item>
    <item>
      <title>Safety of a Novel Upper Esophageal Sphincter Balloon Dilator</title>
      <link>https://escholarship.org/uc/item/3wh0z232</link>
      <description>OBJECTIVE: The shape of esophageal dilators has not changed in over 350 years. Clinical and animal research suggests that the upper esophageal sphincter (UES) is not round but approximates a kidney shape and that cylindrical dilators may be suboptimal. The Infinity UES Dilation System has been developed specifically for the anatomic configuration of the UES. This study evaluates the safety of the UES-specific Infinity Dilation System.
METHODS: All patients undergoing dilation of the UES between January 1, 2022 and September 1, 2023 were included. Demographics, procedure indication, dilator type, minor adverse events, and major complications were abstracted. Minor adverse events, complications, and maximum dilation dimension (mm) were compared between groups.
RESULTS: A total of 477 patients were included. Eight hundred and seventy-three total UES dilations were performed. The primary indications for UES dilation were cricopharyngeus muscle dysfunction (43%) and stenosis from radiation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3wh0z232</guid>
      <pubDate>Sun, 29 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wandell, Grace M</name>
      </author>
      <author>
        <name>Swartwood, Janeth Garcia</name>
      </author>
      <author>
        <name>Brar, Ashar Singh</name>
      </author>
      <author>
        <name>Postma, Gregory N</name>
      </author>
      <author>
        <name>Belafsky, Peter C</name>
      </author>
    </item>
    <item>
      <title>Pediatric Tracheostomy Emergency Readiness Assessment Tool: International Consensus Recommendations</title>
      <link>https://escholarship.org/uc/item/0rm5b867</link>
      <description>OBJECTIVE: To achieve consensus on critical steps and create an assessment tool for actual and simulated pediatric tracheostomy emergencies that incorporates human and systems factors along with tracheostomy-specific steps.
METHODS: A modified Delphi method was used. Using REDCap software, an instrument comprising 29 potential items was circulated to 171 tracheostomy and simulation experts. Consensus criteria were determined a priori with a goal of consolidating and ordering 15 to 25 final items. In the first round, items were rated as "keep" or "remove". In the second and third rounds, experts were asked to rate the importance of each item on a 9-point Likert scale. Items were refined in subsequent iterations based on analysis of results and respondents' comments.
RESULTS: The response rates were 125/171 (73.1%) for the first round, 111/125 (88.8%) for the second round, and 109/125 (87.2%) for the third round. 133 comments were incorporated. Consensus (&amp;gt;60% participants scoring...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0rm5b867</guid>
      <pubDate>Wed, 11 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Schiff, Elliot</name>
      </author>
      <author>
        <name>Propst, Evan J</name>
      </author>
      <author>
        <name>Balakrishnan, Karthik</name>
      </author>
      <author>
        <name>Johnson, Kaalan</name>
      </author>
      <author>
        <name>Lounsbury, David W</name>
      </author>
      <author>
        <name>Brenner, Michael J</name>
      </author>
      <author>
        <name>Tawfik, Marc‐Mina</name>
      </author>
      <author>
        <name>Workgroup, Pediatric Tracheostomy Emergency Readiness</name>
      </author>
      <author>
        <name>Yang, Christina J</name>
      </author>
    </item>
    <item>
      <title>Worsening orbital roof “blow-in” fractures following traumatic brain injury: A report of two cases</title>
      <link>https://escholarship.org/uc/item/5nr6c6c8</link>
      <description>Background: Orbital roof fractures are often the result of high-velocity collisions and are seen in 1-9% of patients with craniofacial trauma. Although the majority of orbital roof fractures are displaced superiorly, a subset results in inferior displacement of fracture fragments, posing a risk for muscle/nerve entrapment and possible blindness. Many of these patients have severe traumatic brain injury (TBI) and, in addition to orbital fractures, also have elevated intracranial pressure (ICP). Management of depressed orbital roof fractures in the setting of severe TBI with elevated ICP represents a management dilemma.
Case Description: Two cases of severe TBI with associated downward displacement of orbital roof fractures were reviewed. Both cases exhibited elevated ICP correlated with the degree of orbital roof fracture depression. Surgical intervention involving elevation and repair of the fractures was undertaken when there was a significant risk of injury to the extraocular...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5nr6c6c8</guid>
      <pubDate>Mon, 11 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Rao, Varun</name>
      </author>
      <author>
        <name>Gerndt, Clayton H</name>
      </author>
      <author>
        <name>Ong, Vera</name>
      </author>
      <author>
        <name>Strong, Edward Bradley</name>
      </author>
      <author>
        <name>Shahlaie, Kiarash</name>
      </author>
    </item>
    <item>
      <title>Anatomy-Specific Classification Model Using Label-Free FLIm to Aid Intraoperative Surgical Guidance of Head and Neck Cancer</title>
      <link>https://escholarship.org/uc/item/4039z18c</link>
      <description>Intraoperative identification of head and neck cancer tissue is essential to achieve complete tumor resection and mitigate tumor recurrence. Mesoscopic fluorescence lifetime imaging (FLIm) of intrinsic tissue fluorophores emission has demonstrated the potential to demarcate the extent of the tumor in patients undergoing surgical procedures of the oral cavity and the oropharynx. Here, we report FLIm-based classification methods using standard machine learning models that account for the diverse anatomical and biochemical composition across the head and neck anatomy to improve tumor region identification. Three anatomy-specific binary classification models were developed (i.e., "base of tongue," "palatine tonsil," and "oral tongue"). FLIm data from patients (N = 85) undergoing upper aerodigestive oncologic surgery were used to train and validate the classification models using a leave-one-patient-out cross-validation method. These models were evaluated for two classification tasks:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4039z18c</guid>
      <pubDate>Sat, 9 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hassan, Mohamed Abul</name>
      </author>
      <author>
        <name>Weyers, Brent W</name>
        <uri>https://orcid.org/0000-0002-1939-3401</uri>
      </author>
      <author>
        <name>Bec, Julien</name>
        <uri>https://orcid.org/0000-0003-1222-4071</uri>
      </author>
      <author>
        <name>Fereidouni, Farzad</name>
        <uri>https://orcid.org/0000-0001-6790-0888</uri>
      </author>
      <author>
        <name>Qi, Jinyi</name>
        <uri>https://orcid.org/0000-0002-5428-0322</uri>
      </author>
      <author>
        <name>Gui, Dorina</name>
        <uri>https://orcid.org/0000-0002-1500-6689</uri>
      </author>
      <author>
        <name>Bewley, Arnaud F</name>
        <uri>https://orcid.org/0000-0002-1524-1806</uri>
      </author>
      <author>
        <name>Abouyared, Marianne</name>
      </author>
      <author>
        <name>Farwell, D Gregory</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Marcu, Laura</name>
        <uri>https://orcid.org/0000-0003-2369-0748</uri>
      </author>
    </item>
    <item>
      <title>Early Detection of Lymph Node Metastasis Using Primary Head and Neck Cancer Computed Tomography and Fluorescence Lifetime Imaging</title>
      <link>https://escholarship.org/uc/item/0vt7c6t1</link>
      <description>&lt;b&gt;Objectives&lt;/b&gt;: Early detection and accurate diagnosis of lymph node metastasis (LNM) in head and neck cancer (HNC) are crucial for enhancing patient prognosis and survival rates. Current imaging methods have limitations, necessitating new evaluation of new diagnostic techniques. This study investigates the potential of combining pre-operative CT and intra-operative fluorescence lifetime imaging (FLIm) to enhance LNM prediction in HNC using primary tumor signatures. &lt;b&gt;Methods&lt;/b&gt;: CT and FLIm data were collected from 46 HNC patients. A total of 42 FLIm features and 924 CT radiomic features were extracted from the primary tumor site and fused. A support vector machine (SVM) model with a radial basis function kernel was trained to predict LNM. Hyperparameter tuning was conducted using 10-fold nested cross-validation. Prediction performance was evaluated using balanced accuracy (bACC) and the area under the ROC curve (AUC). &lt;b&gt;Results&lt;/b&gt;: The model, leveraging combined CT and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0vt7c6t1</guid>
      <pubDate>Fri, 1 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Yuan, Nimu</name>
        <uri>https://orcid.org/0009-0003-8434-2015</uri>
      </author>
      <author>
        <name>Hassan, Mohamed A</name>
      </author>
      <author>
        <name>Ehrlich, Katjana</name>
      </author>
      <author>
        <name>Weyers, Brent W</name>
      </author>
      <author>
        <name>Biddle, Garrick</name>
      </author>
      <author>
        <name>Ivanovic, Vladimir</name>
      </author>
      <author>
        <name>Raslan, Osama AA</name>
      </author>
      <author>
        <name>Gui, Dorina</name>
        <uri>https://orcid.org/0000-0002-1500-6689</uri>
      </author>
      <author>
        <name>Abouyared, Marianne</name>
      </author>
      <author>
        <name>Bewley, Arnaud F</name>
        <uri>https://orcid.org/0000-0002-1524-1806</uri>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Farwell, D Gregory</name>
      </author>
      <author>
        <name>Marcu, Laura</name>
        <uri>https://orcid.org/0000-0003-2369-0748</uri>
      </author>
      <author>
        <name>Qi, Jinyi</name>
        <uri>https://orcid.org/0000-0002-5428-0322</uri>
      </author>
    </item>
    <item>
      <title>Is Postoperative Nasal Stenting Necessary After Primary Cleft Lip and Nose Repair?</title>
      <link>https://escholarship.org/uc/item/7g7698mn</link>
      <description>The repair of an infant with cleft lip includes treatment of the nasal deformity using surgical repositioning of the nasal cartilages. In some cases, the nose is molded before surgery, termed nasoalveolar molding, and in others, postoperatively with nostril stents for a variable amount of time. This best practice evaluation fails to make a definitive evidence-based conclusion, yet the benefits of stenting seem to outweigh the risks.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7g7698mn</guid>
      <pubDate>Wed, 9 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Marston, Alexander P</name>
      </author>
      <author>
        <name>Tollefson, Travis T</name>
        <uri>https://orcid.org/0000-0002-8658-8647</uri>
      </author>
    </item>
    <item>
      <title>Rates, Indications, and Speech Perception Outcomes of Revision Cochlear Implantations.</title>
      <link>https://escholarship.org/uc/item/4g70n032</link>
      <description>Revision cochlear implant (RCI) is a growing burden on cochlear implant programs. While reports on RCI rate are frequent, outcome measures are limited. The objectives of the current study were to: (1) evaluate RCI rate, (2) classify indications, (3) delineate the pre-RCI clinical course, and (4) measure surgical and speech perception outcomes, in a large cohort of patients implanted in a tertiary referral center between 1989-2018. Retrospective data review was performed and included patient demographics, medical records, and audiologic outcomes. Results indicated that RCI rate was 11.7% (172/1465), with a trend of increased RCI load over the years. The main indications for RCI were device-related failures (soft-45.4%, hard-23.8%), medical failure (14%), trauma (8.1%), and surgical failure (6.4%). Success rate was 98.8%. Children comprised 78% (134) of the cohort and were more likely than adults to undergo RCI. Most (70%) of the RCIs were performed within 10 years from primary...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4g70n032</guid>
      <pubDate>Wed, 9 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Sagiv, Doron</name>
      </author>
      <author>
        <name>Yaar-Soffer, Yifat</name>
      </author>
      <author>
        <name>Yakir, Ziva</name>
      </author>
      <author>
        <name>Henkin, Yael</name>
      </author>
      <author>
        <name>Shapira, Yisgav</name>
      </author>
    </item>
    <item>
      <title>The State of Craniomaxillofacial Trauma Care in Low‐ and Middle‐Income Countries: A Scoping Review</title>
      <link>https://escholarship.org/uc/item/8r8417q1</link>
      <description>Objective: This scoping review aims to contribute a descriptive analysis of the craniomaxillofacial trauma (CMF trauma) literature in low- and middle-income countries (LMICs) to identify knowledge gaps, direct future research, and inform policy.
Data Sources: PubMed/MEDLINE, Cochrane Review, EMBASE, ClinicalTrials.gov, and Google Scholar from January 1, 2012 to December 10, 2023.
Review Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guided reporting, and the PRISMA flowchart documented database searches. Specific, predefined search terms and inclusion criteria were used for screening, and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)&amp;nbsp;checklist was used for quality assessment. The search yielded 54 articles, with 13 meeting the inclusion criteria. Key findings were summarized and divided into 7 categories.
Results: There were 10,420 patients (7739 [74.3%] male, 2681...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8r8417q1</guid>
      <pubDate>Mon, 9 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Elwell, Zachary</name>
      </author>
      <author>
        <name>Candelo, Estephania</name>
      </author>
      <author>
        <name>Srinivasan, Tarika</name>
      </author>
      <author>
        <name>Nuss, Sarah</name>
      </author>
      <author>
        <name>Zalaquett, Nader</name>
      </author>
      <author>
        <name>Tuyishimire, Gratien</name>
      </author>
      <author>
        <name>Ncogoza, Isaie</name>
      </author>
      <author>
        <name>Jean‐Gilles, Patrick Marc</name>
      </author>
      <author>
        <name>Legbo, Jacob Ndas</name>
      </author>
      <author>
        <name>Tollefson, Travis</name>
        <uri>https://orcid.org/0000-0002-8658-8647</uri>
      </author>
      <author>
        <name>Shaye, David</name>
      </author>
    </item>
    <item>
      <title>Cell derived matrices from bovine corneal endothelial cells as a model to study cellular dysfunction</title>
      <link>https://escholarship.org/uc/item/37t8t6hz</link>
      <description>PURPOSE: Fuchs endothelial corneal dystrophy (FECD) is a progressive corneal disease that impacts the structure and stiffness of the Descemet's membrane (DM), the substratum for corneal endothelial cells (CECs). These structural alterations of the DM could contribute to the loss of the CECs resulting in corneal edema and blindness. Oxidative stress and transforming growth factor-β (TGF-β) pathways have been implicated in endothelial cell loss and endothelial to mesenchymal transition of CECs in FECD. Ascorbic acid (AA) is found at high concentrations in FECD and its impact on CEC survival has been investigated. However, how TGF-β and AA effect the composition and rigidity of the CEC's matrix remains unknown.
METHODS: In this study, we investigated the effect of AA, TGF-β1 and TGF-β3 on the deposition, ultrastructure, stiffness, and composition of the extracellular matrix (ECM) secreted by primary bovine corneal endothelial cells (BCECs).
RESULTS: Immunofluorescence and electron...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/37t8t6hz</guid>
      <pubDate>Wed, 4 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Jalilian, Iman</name>
      </author>
      <author>
        <name>Muppala, Santoshi</name>
      </author>
      <author>
        <name>Ali, Maryam</name>
      </author>
      <author>
        <name>Anderson, Johnathon D</name>
        <uri>https://orcid.org/0000-0001-5404-2298</uri>
      </author>
      <author>
        <name>Phinney, Brett</name>
        <uri>https://orcid.org/0000-0003-3870-3302</uri>
      </author>
      <author>
        <name>Salemi, Michelle</name>
      </author>
      <author>
        <name>Wilmarth, Phillip A</name>
      </author>
      <author>
        <name>Murphy, Christopher J</name>
      </author>
      <author>
        <name>Thomasy, Sara M</name>
        <uri>https://orcid.org/0000-0001-5617-9677</uri>
      </author>
      <author>
        <name>Raghunathan, VijayKrishna</name>
      </author>
    </item>
    <item>
      <title>Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis</title>
      <link>https://escholarship.org/uc/item/9f6716fw</link>
      <description>Transforming growth factor beta (TGFβ) activity is linked to metastasis in many cancer types, but whether TGFβ activity is necessary for squamous cell carcinoma (SCC) lung metastasis has not been studied. Here we used a lung metastatic SCC model derived from keratin 15 (K15). Kras&lt;sup&gt;G12D&lt;/sup&gt;.Smad4&lt;sup&gt;-/-&lt;/sup&gt; SCC and human SCC specimens to identify metastasis drivers and test therapeutic interventions. We demonstrated that a TGFβ receptor (TGFβR) inhibitor reduced lung metastasis in mouse SCC correlating with reduced CD11b&lt;sup&gt;+&lt;/sup&gt;/Ly6G&lt;sup&gt;+&lt;/sup&gt; myeloid cells positive for inducible nitric oxide synthase (iNOS). Further, TGFβ activity and iNOS were higher in primary human oral SCCs with metastasis than SCCs without metastasis. Consistently, either depleting myeloid cells with anti-Gr1 antibody or inhibiting iNOS with L-N6-(1-iminoethyl)-l-lysine (L-NIL) reduced SCC lung metastasis. L-NIL treated tumor-bearing mice exhibited reductions in tumor-infiltrating myeloid cells...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9f6716fw</guid>
      <pubDate>Sun, 1 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Li, Xing</name>
      </author>
      <author>
        <name>Ke, Yao</name>
      </author>
      <author>
        <name>Hernandez, Ariel L</name>
      </author>
      <author>
        <name>Yu, Jingjing</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Hall, Spencer C</name>
      </author>
      <author>
        <name>Nolan, Kyle</name>
      </author>
      <author>
        <name>Wang, Jing H</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Perspectives on the state of cleft lip and cleft palate patient care in Africa</title>
      <link>https://escholarship.org/uc/item/28t5b7wz</link>
      <description>PURPOSE OF REVIEW: Patients with cleft lip -palate (CLP) experience morbidity and social stigma, particularly in low-income and middle-income countries (LMICs) such as those of sub-Saharan Africa (SSA). Delays in treatment secondary either to lack of awareness, skills, equipment and consumables; poor health infrastructure, limited resources or a combination of them, has led to SSA having the highest rates of death and second highest rates of disability-adjusted life years in patients with CLP globally. Here we review current perspectives on the state of comprehensive cleft lip and palate repair in Africa.
RECENT FINDINGS: To bridge gaps in government health services, nongovernmental organizations (NGOs) have emerged to provide care through short-term surgical interventions (STSIs). These groups can effect change through direct provision of care, whereas others strengthen internal system. However, sustainability is lacking as there continue to be barriers to achieving comprehensive...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/28t5b7wz</guid>
      <pubDate>Sat, 31 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Liu, Rui Han</name>
      </author>
      <author>
        <name>Manana, Wayne</name>
      </author>
      <author>
        <name>Tollefson, Travis T</name>
        <uri>https://orcid.org/0000-0002-8658-8647</uri>
      </author>
      <author>
        <name>Ntirenganya, Faustin</name>
      </author>
      <author>
        <name>Shaye, David A</name>
      </author>
    </item>
    <item>
      <title>Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma</title>
      <link>https://escholarship.org/uc/item/50n0w1pt</link>
      <description>BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is a debilitating disease with poor survival rates. While the epidermal growth factor receptor (EGFR)-targeting antibody Cetuximab is approved for treatment, responses are limited and the molecular mechanisms driving resistance remain incompletely understood.
METHODS: To better understand how cells survive without EGFR activity, we developed an EGFR knockout derivative of the UM-SCC-92 cell line using CRISPR/Cas9 technology. We then characterized changes to the transcriptome with RNAseq and changes in response to kinase inhibitors with resazurin cell viability assays. Finally, we tested if inhibitors with activity in the EGFR knockout model also had synergistic activity in combination with EGFR inhibitors in either wild type UM-SCC-92 cells or a known Cetuximab-resistant model.
RESULTS: Functional and molecular analysis showed that knockout cells had decreased cell proliferation, upregulation of FGFR1 expression, and an...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/50n0w1pt</guid>
      <pubDate>Sat, 6 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ludwig, Megan L</name>
      </author>
      <author>
        <name>Michmerhuizen, Nicole L</name>
      </author>
      <author>
        <name>Wang, Jiayu</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Majchrowski, Behirda K</name>
      </author>
      <author>
        <name>Nimmagadda, Sai</name>
      </author>
      <author>
        <name>Zhai, Jingyi</name>
      </author>
      <author>
        <name>Bhangale, Apurva</name>
      </author>
      <author>
        <name>Kulkarni, Aditi</name>
      </author>
      <author>
        <name>Jiang, Hui</name>
      </author>
      <author>
        <name>Swiecicki, Paul L</name>
      </author>
      <author>
        <name>Brenner, J Chad</name>
      </author>
    </item>
    <item>
      <title>IL-22RA2 Is a SMAD7 Target Mediating the Alleviation of Dermatitis and Psoriatic Phenotypes in Mice</title>
      <link>https://escholarship.org/uc/item/6g25x8j9</link>
      <description>Long-term management of inflammatory skin diseases is challenging because of side effects from repeated use of systemic treatments or topical corticosteroids. This study sought to identify the mechanisms and developmental therapeutics for these diseases using genetic models and pharmacological approaches. We found that mice overexpressing SMAD7 in keratinocytes but not mice overexpressing the N-terminal domain of SMAD7 (i.e., N-SMAD7) were resistant to imiquimod-induced T helper 1/17- and T helper 2-type inflammation. We generated a Tat-PYC-SMAD7 (truncated SMAD7 protein encompassing C-terminal SMAD7 and PY motif fused with cell-penetrating Tat peptide). Topically applied Tat-PYC-SMAD7 to inflamed skin entered cells upon contact and attenuated imiquimod-, 2,4-dinitrofluorobenzene-, and tape-stripping-induced inflammation. RNA-sequencing analyses of mouse skin exposed to these insults showed that in addition to inhibiting TGFβ/NF-κB, SMAD7 blunted IL-22/signal transducer and activator...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6g25x8j9</guid>
      <pubDate>Sat, 8 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ke, Yao</name>
      </author>
      <author>
        <name>Li, Ben-Zheng</name>
      </author>
      <author>
        <name>Nguyen, Khoa</name>
      </author>
      <author>
        <name>Wang, Donna</name>
      </author>
      <author>
        <name>Wang, Suyan</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Stratification of surgical margin distances by the millimeter on local recurrence in oral cavity cancer: A systematic review and meta‐analysis</title>
      <link>https://escholarship.org/uc/item/8rt5p8xj</link>
      <description>There are limited data supporting the commonly suggested 5 mm margin cutoff as the optimum value in defining clear margins in oral cancer. A database search of Pubmed/Medline, Web of Science, and EBSCOhost was performed from inception to June 2022. A random-effects model was chosen for this meta-analysis. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed throughout this study. Seven studies met study criteria (2215 patients). The risk ratio was significantly higher for margins &amp;lt;5 mm when compared to those ≥5 mm (2.09 (95%CI: 1.53-2.86, I&lt;sup&gt;2&lt;/sup&gt; &amp;nbsp;= 0.47)). Subgroup analysis (I&lt;sup&gt;2&lt;/sup&gt; &amp;nbsp;=&amp;nbsp;0.15) of margin distances of 0.0-0.9, 1.0-1.9, 2.0-2.9, 3.0-3.9, and 4.0-4.9 mm calculated risk ratios for local recurrence of 2.96, 2.01, 2.17, 1.8, and 0.98, respectively. Margins between 4.0 and 4.9 mm had similar risk ratios for local recurrence compared to ≥5 mm, while margins &amp;lt;4.0 were significantly higher.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8rt5p8xj</guid>
      <pubDate>Wed, 15 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Young, Kurtis</name>
      </author>
      <author>
        <name>Bulosan, Hannah</name>
      </author>
      <author>
        <name>Kida, Carley C</name>
      </author>
      <author>
        <name>Bewley, Arnaud F</name>
        <uri>https://orcid.org/0000-0002-1524-1806</uri>
      </author>
      <author>
        <name>Abouyared, Marianne</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
    </item>
    <item>
      <title>Portrait of a Surgeon: Artificial Intelligence Reflections</title>
      <link>https://escholarship.org/uc/item/5h25k5w5</link>
      <description>Text-to-image artificial intelligence (AI) programs are popular public-facing tools that generate novel images based on user prompts. Given that they are trained from Internet data, they may reflect societal biases, as has been shown for text-to-text large language model programs. We sought to investigate whether 3 common text-to-image AI systems recapitulated stereotypes held about surgeons and other health care professionals. All platforms queried were able to reproduce common aspects of the profession including attire, equipment, and background settings, but there were differences between programs most notably regarding visible race and gender diversity. Thus, historical stereotypes of surgeons may be reinforced by the public's use of text-to-image AI systems, particularly those without procedures to regulate generated output. As AI systems become more ubiquitous, understanding the implications of their use in health care and for health care-adjacent purposes is critical to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5h25k5w5</guid>
      <pubDate>Sat, 27 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Farlow, Janice L</name>
      </author>
      <author>
        <name>Abouyared, Marianne</name>
      </author>
      <author>
        <name>Rettig, Eleni M</name>
      </author>
      <author>
        <name>Kejner, Alexandra</name>
      </author>
      <author>
        <name>Edwards, Heather A</name>
      </author>
      <author>
        <name>Patel, Rusha</name>
      </author>
    </item>
    <item>
      <title>International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19</title>
      <link>https://escholarship.org/uc/item/3467k55c</link>
      <description>STATEMENT: The International Society for Cellular and Gene Therapies (ISCT) and the International Society for Extracellular Vesicles (ISEV) recognize the potential of extracellular vesicles (EVs, including exosomes) from mesenchymal stromal cells (MSCs) and possibly other cell sources as treatments for COVID-19. Research and trials in this area are encouraged. However, ISEV and ISCT do not currently endorse the use of EVs or exosomes for any purpose in COVID-19, including but not limited to reducing cytokine storm, exerting regenerative effects or delivering drugs, pending the generation of appropriate manufacturing and quality control provisions, pre-clinical safety and efficacy data, rational clinical trial design and proper regulatory oversight.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3467k55c</guid>
      <pubDate>Mon, 8 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Börger, Verena</name>
      </author>
      <author>
        <name>Weiss, Daniel J</name>
      </author>
      <author>
        <name>Anderson, Johnathon D</name>
        <uri>https://orcid.org/0000-0001-5404-2298</uri>
      </author>
      <author>
        <name>Borràs, Francesc E</name>
      </author>
      <author>
        <name>Bussolati, Benedetta</name>
      </author>
      <author>
        <name>Carter, David RF</name>
      </author>
      <author>
        <name>Dominici, Massimo</name>
      </author>
      <author>
        <name>Falcón-Pérez, Juan M</name>
      </author>
      <author>
        <name>Gimona, Mario</name>
      </author>
      <author>
        <name>Hill, Andrew F</name>
      </author>
      <author>
        <name>Hoffman, Andrew M</name>
      </author>
      <author>
        <name>de Kleijn, Dominique</name>
      </author>
      <author>
        <name>Levine, Bruce L</name>
      </author>
      <author>
        <name>Lim, Rebecca</name>
      </author>
      <author>
        <name>Lötvall, Jan</name>
      </author>
      <author>
        <name>Mitsialis, S Alex</name>
      </author>
      <author>
        <name>Monguió-Tortajada, Marta</name>
      </author>
      <author>
        <name>Muraca, Maurizio</name>
      </author>
      <author>
        <name>Nieuwland, Rienk</name>
      </author>
      <author>
        <name>Nowocin, Anna</name>
      </author>
      <author>
        <name>O'Driscoll, Lorraine</name>
      </author>
      <author>
        <name>Ortiz, Luis A</name>
      </author>
      <author>
        <name>Phinney, Donald G</name>
      </author>
      <author>
        <name>Reischl, Ilona</name>
      </author>
      <author>
        <name>Rohde, Eva</name>
      </author>
      <author>
        <name>Sanzenbacher, Ralf</name>
      </author>
      <author>
        <name>Théry, Clotilde</name>
      </author>
      <author>
        <name>Toh, Wei Seong</name>
      </author>
      <author>
        <name>Witwer, Kenneth W</name>
      </author>
      <author>
        <name>Lim, Sai Kiang</name>
      </author>
      <author>
        <name>Giebel, Bernd</name>
      </author>
    </item>
    <item>
      <title>Computer assisted skull base surgery: a contemporary review</title>
      <link>https://escholarship.org/uc/item/29n489pf</link>
      <description>Skull base surgery has evolved significantly since Harvey Cushing's first descriptions in the early 1900s. Computer aided surgery (CAS) applications continue to expand; they include virtual surgical planning, augmented and virtual reality, 3D printing of models/cutting guides/implants, surgical navigation, and intraoperative imaging. The authors will review the current skull base CAS literature and propose a computer aided surgical workflow categorizing these applications into 3 phases: 1) Virtual planning, 2) Surgical execution, 3) Intraoperative verification.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/29n489pf</guid>
      <pubDate>Mon, 19 Feb 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Bartella, Alexander K</name>
      </author>
      <author>
        <name>Hoshal, Steven G</name>
        <uri>https://orcid.org/0000-0001-6760-3517</uri>
      </author>
      <author>
        <name>Lethaus, Bernd</name>
      </author>
      <author>
        <name>Strong, E Bradley</name>
      </author>
    </item>
    <item>
      <title>Association of Social Determinants of Health with Time to Diagnosis and Treatment Outcomes in Idiopathic Subglottic Stenosis</title>
      <link>https://escholarship.org/uc/item/3cn4j99b</link>
      <description>OBJECTIVES: To examine whether social determinants of health (SDH) factors are associated with time to diagnosis, treatment selection, and time to recurrent surgical intervention in idiopathic subglottic stenosis (iSGS) patients.
METHODS: Adult patients with diagnosed iSGS were recruited prospectively (2015-2017) via clinical providers as part of the North American Airway Collaborative (NoAAC) and via an online iSGS support community on Facebook. Patient-specific SDH factors included highest educational attainment (self-reported), median household income (matched from home zip code via U.S. Census data), and number of close friends (self-reported) as a measure of social support. Main outcomes of interest were time to disease diagnosis (years from symptom onset), treatment selection (endoscopic dilation [ED] vs cricotracheal resection [CTR] vs endoscopic resection with adjuvant medical therapy [ERMT]), and time to recurrent surgical intervention (number of days from initial surgical...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3cn4j99b</guid>
      <pubDate>Fri, 2 Feb 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Lee, Jaclyn</name>
      </author>
      <author>
        <name>Huang, Li-Ching</name>
      </author>
      <author>
        <name>Berry, Lynn D</name>
      </author>
      <author>
        <name>Anderson, Catherine</name>
      </author>
      <author>
        <name>Amin, Milan R</name>
      </author>
      <author>
        <name>Benninger, Michael S</name>
      </author>
      <author>
        <name>Blumin, Joel H</name>
      </author>
      <author>
        <name>Bock, Jonathan M</name>
      </author>
      <author>
        <name>Bryson, Paul C</name>
      </author>
      <author>
        <name>Castellanos, Paul F</name>
      </author>
      <author>
        <name>Chen, Sheau-Chiann</name>
      </author>
      <author>
        <name>Clary, Matthew S</name>
      </author>
      <author>
        <name>Cohen, Seth M</name>
      </author>
      <author>
        <name>Crawley, Brianna K</name>
        <uri>https://orcid.org/0000-0003-1011-0433</uri>
      </author>
      <author>
        <name>Dailey, Seth H</name>
      </author>
      <author>
        <name>Daniero, James J</name>
      </author>
      <author>
        <name>de. Alarcon, Alessandro</name>
      </author>
      <author>
        <name>Donovan, Donald T</name>
      </author>
      <author>
        <name>Edell, Eric S</name>
      </author>
      <author>
        <name>Ekbom, Dale C</name>
      </author>
      <author>
        <name>Fink, Daniel S</name>
      </author>
      <author>
        <name>Franco, Ramon A</name>
      </author>
      <author>
        <name>Garrett, C Gaelyn</name>
      </author>
      <author>
        <name>Guardiani, Elizabeth A</name>
      </author>
      <author>
        <name>Hillel, Alexander T</name>
      </author>
      <author>
        <name>Hoffman, Henry T</name>
      </author>
      <author>
        <name>Hogikyan, Norman D</name>
      </author>
      <author>
        <name>Howell, Rebecca J</name>
      </author>
      <author>
        <name>Hussain, Lena K</name>
      </author>
      <author>
        <name>Johns, Michael M</name>
      </author>
      <author>
        <name>Kasperbauer, Jan L</name>
      </author>
      <author>
        <name>Khosla, Sid M</name>
      </author>
      <author>
        <name>Kinnard, Cheryl</name>
      </author>
      <author>
        <name>Kupfer, Robbi A</name>
      </author>
      <author>
        <name>Langerman, Alexander J</name>
      </author>
      <author>
        <name>Lentz, Robert J</name>
      </author>
      <author>
        <name>Lorenz, Robert R</name>
      </author>
      <author>
        <name>Lott, David G</name>
      </author>
      <author>
        <name>Lowery, Anne S</name>
      </author>
      <author>
        <name>Makani, Samir S</name>
      </author>
      <author>
        <name>Maldonado, Fabien</name>
      </author>
      <author>
        <name>Mannion, Kyle</name>
      </author>
      <author>
        <name>Matrka, Laura</name>
      </author>
      <author>
        <name>McWhorter, Andrew J</name>
      </author>
      <author>
        <name>Merati, Albert L</name>
      </author>
      <author>
        <name>Mori, Matthew</name>
      </author>
      <author>
        <name>Netterville, James L</name>
      </author>
      <author>
        <name>O’Dell, Karla</name>
      </author>
      <author>
        <name>Ongkasuwan, Julina</name>
      </author>
      <author>
        <name>Postma, Gregory N</name>
      </author>
      <author>
        <name>Reder, Lindsay S</name>
      </author>
      <author>
        <name>Rohde, Sarah L</name>
      </author>
      <author>
        <name>Richardson, Brent E</name>
      </author>
      <author>
        <name>Rickman, Otis B</name>
      </author>
      <author>
        <name>Rosen, Clark A</name>
      </author>
      <author>
        <name>Rutter, Michael J</name>
      </author>
      <author>
        <name>Sandhu, Guri S</name>
      </author>
      <author>
        <name>Schindler, Joshua S</name>
      </author>
      <author>
        <name>Schneider, G Todd</name>
      </author>
      <author>
        <name>Shah, Rupali N</name>
      </author>
      <author>
        <name>Sikora, Andrew G</name>
      </author>
      <author>
        <name>Sinard, Robert J</name>
      </author>
      <author>
        <name>Smith, Marshall E</name>
      </author>
      <author>
        <name>Smith, Libby J</name>
      </author>
      <author>
        <name>Soliman, Ahmed MS</name>
      </author>
      <author>
        <name>Sveinsdóttir, Sigríður</name>
      </author>
      <author>
        <name>Van Daele, Douglas J</name>
      </author>
      <author>
        <name>Veivers, David</name>
      </author>
      <author>
        <name>Verma, Sunil P</name>
      </author>
      <author>
        <name>Weinberger, Paul M</name>
      </author>
      <author>
        <name>Weissbrod, Philip A</name>
      </author>
      <author>
        <name>Wootten, Christopher T</name>
      </author>
      <author>
        <name>Shyr, Yu</name>
      </author>
      <author>
        <name>Francis, David O</name>
      </author>
      <author>
        <name>Gelbard, Alexander</name>
      </author>
    </item>
    <item>
      <title>Commentary on Benjamin et al.'s “Assessing the Prevalence of Craniomaxillofacial Injuries Among Helmeted and Unhelmeted Electric Scooter Users”: A Call to Action for Logical Protection</title>
      <link>https://escholarship.org/uc/item/9k55930h</link>
      <description>Commentary on Benjamin et al.'s “Assessing the Prevalence of Craniomaxillofacial Injuries Among Helmeted and Unhelmeted Electric Scooter Users”: A Call to Action for Logical Protection</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9k55930h</guid>
      <pubDate>Wed, 31 Jan 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Shehan, Jennifer N</name>
      </author>
      <author>
        <name>Tollefson, Travis T</name>
        <uri>https://orcid.org/0000-0002-8658-8647</uri>
      </author>
    </item>
    <item>
      <title>International Consensus Statement on Obstructive Sleep Apnea</title>
      <link>https://escholarship.org/uc/item/6xx9q57f</link>
      <description>BACKGROUND: Evaluation and interpretation of the literature on obstructive sleep apnea (OSA) allows for consolidation and determination of the key factors important for clinical management of the adult OSA patient. Toward this goal, an international collaborative of multidisciplinary experts in sleep apnea evaluation and treatment have produced the International Consensus statement on Obstructive Sleep Apnea (ICS:OSA).
METHODS: Using previously defined methodology, focal topics in OSA were assigned as literature review (LR), evidence-based review (EBR), or evidence-based review with recommendations (EBR-R) formats. Each topic incorporated the available and relevant evidence which was summarized and graded on study quality. Each topic and section underwent iterative review and the ICS:OSA was created and reviewed by all authors for consensus.
RESULTS: The ICS:OSA addresses OSA syndrome definitions, pathophysiology, epidemiology, risk factors for disease, screening methods, diagnostic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6xx9q57f</guid>
      <pubDate>Wed, 10 Jan 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Chang, Jolie L</name>
        <uri>https://orcid.org/0000-0002-0778-1044</uri>
      </author>
      <author>
        <name>Goldberg, Andrew N</name>
      </author>
      <author>
        <name>Alt, Jeremiah A</name>
      </author>
      <author>
        <name>Mohammed, Alzoubaidi</name>
      </author>
      <author>
        <name>Ashbrook, Liza</name>
      </author>
      <author>
        <name>Auckley, Dennis</name>
      </author>
      <author>
        <name>Ayappa, Indu</name>
      </author>
      <author>
        <name>Bakhtiar, Hira</name>
      </author>
      <author>
        <name>Barrera, José E</name>
      </author>
      <author>
        <name>Bartley, Bethany L</name>
      </author>
      <author>
        <name>Billings, Martha E</name>
      </author>
      <author>
        <name>Boon, Maurits S</name>
      </author>
      <author>
        <name>Bosschieter, Pien</name>
      </author>
      <author>
        <name>Braverman, Itzhak</name>
      </author>
      <author>
        <name>Brodie, Kara</name>
      </author>
      <author>
        <name>Cabrera‐Muffly, Cristina</name>
      </author>
      <author>
        <name>Caesar, Ray</name>
      </author>
      <author>
        <name>Cahali, Michel B</name>
      </author>
      <author>
        <name>Cai, Yi</name>
      </author>
      <author>
        <name>Cao, Michelle</name>
      </author>
      <author>
        <name>Capasso, Robson</name>
      </author>
      <author>
        <name>Caples, Sean M</name>
      </author>
      <author>
        <name>Chahine, Lana M</name>
      </author>
      <author>
        <name>Chang, Corissa P</name>
      </author>
      <author>
        <name>Chang, Katherine W</name>
      </author>
      <author>
        <name>Chaudhary, Nilika</name>
      </author>
      <author>
        <name>Cheong, Crystal SJ</name>
      </author>
      <author>
        <name>Chowdhuri, Susmita</name>
      </author>
      <author>
        <name>Cistulli, Peter A</name>
      </author>
      <author>
        <name>Claman, David</name>
      </author>
      <author>
        <name>Collen, Jacob</name>
      </author>
      <author>
        <name>Coughlin, Kevin C</name>
      </author>
      <author>
        <name>Creamer, Jennifer</name>
      </author>
      <author>
        <name>Davis, Eric M</name>
      </author>
      <author>
        <name>Dupuy‐McCauley, Kara L</name>
      </author>
      <author>
        <name>Durr, Megan L</name>
      </author>
      <author>
        <name>Dutt, Mohan</name>
      </author>
      <author>
        <name>Ali, Mazen El</name>
      </author>
      <author>
        <name>Elkassabany, Nabil M</name>
      </author>
      <author>
        <name>Epstein, Lawrence J</name>
      </author>
      <author>
        <name>Fiala, Justin A</name>
      </author>
      <author>
        <name>Freedman, Neil</name>
      </author>
      <author>
        <name>Gill, Kirat</name>
      </author>
      <author>
        <name>Gillespie, M Boyd</name>
      </author>
      <author>
        <name>Golisch, Lea</name>
      </author>
      <author>
        <name>Gooneratne, Nalaka</name>
      </author>
      <author>
        <name>Gottlieb, Daniel J</name>
      </author>
      <author>
        <name>Green, Katherine K</name>
      </author>
      <author>
        <name>Gulati, Arushi</name>
      </author>
      <author>
        <name>Gurubhagavatula, Indira</name>
      </author>
      <author>
        <name>Hayward, Nathan</name>
      </author>
      <author>
        <name>Hoff, Paul T</name>
      </author>
      <author>
        <name>Hoffmann, Oliver MG</name>
      </author>
      <author>
        <name>Holfinger, Steven J</name>
      </author>
      <author>
        <name>Hsia, Jennifer</name>
      </author>
      <author>
        <name>Huntley, Colin</name>
      </author>
      <author>
        <name>Huoh, Kevin C</name>
      </author>
      <author>
        <name>Huyett, Phillip</name>
      </author>
      <author>
        <name>Inala, Sanjana</name>
      </author>
      <author>
        <name>Ishman, Stacey L</name>
      </author>
      <author>
        <name>Jella, Tarun K</name>
      </author>
      <author>
        <name>Jobanputra, Aesha M</name>
      </author>
      <author>
        <name>Johnson, Andrew P</name>
      </author>
      <author>
        <name>Junna, Mithri R</name>
      </author>
      <author>
        <name>Kado, Jenna T</name>
      </author>
      <author>
        <name>Kaffenberger, Thomas M</name>
      </author>
      <author>
        <name>Kapur, Vishesh K</name>
      </author>
      <author>
        <name>Kezirian, Eric J</name>
        <uri>https://orcid.org/0000-0003-3808-4521</uri>
      </author>
      <author>
        <name>Khan, Meena</name>
      </author>
      <author>
        <name>Kirsch, Douglas B</name>
      </author>
      <author>
        <name>Kominsky, Alan</name>
      </author>
      <author>
        <name>Kryger, Meir</name>
      </author>
      <author>
        <name>Krystal, Andrew D</name>
      </author>
      <author>
        <name>Kushida, Clete A</name>
      </author>
      <author>
        <name>Kuzniar, Thomas J</name>
      </author>
      <author>
        <name>Lam, Derek J</name>
      </author>
      <author>
        <name>Lettieri, Christopher J</name>
      </author>
      <author>
        <name>Lim, Diane C</name>
      </author>
      <author>
        <name>Lin, Hsin‐Ching</name>
      </author>
      <author>
        <name>Liu, Stanley YC</name>
      </author>
      <author>
        <name>MacKay, Stuart G</name>
      </author>
      <author>
        <name>Magalang, Ulysses J</name>
      </author>
      <author>
        <name>Malhotra, Atul</name>
      </author>
      <author>
        <name>Mansukhani, Meghna P</name>
      </author>
      <author>
        <name>Maurer, Joachim T</name>
      </author>
      <author>
        <name>May, Anna M</name>
      </author>
      <author>
        <name>Mitchell, Ron B</name>
      </author>
      <author>
        <name>Mokhlesi, Babak</name>
      </author>
      <author>
        <name>Mullins, Anna E</name>
      </author>
      <author>
        <name>Nada, Eman M</name>
      </author>
      <author>
        <name>Naik, Sreelatha</name>
      </author>
      <author>
        <name>Nokes, Brandon</name>
      </author>
      <author>
        <name>Olson, Michael D</name>
      </author>
      <author>
        <name>Pack, Allan I</name>
      </author>
      <author>
        <name>Pang, Edward B</name>
      </author>
      <author>
        <name>Pang, Kenny P</name>
      </author>
      <author>
        <name>Patil, Susheel P</name>
      </author>
      <author>
        <name>Van de Perck, Eli</name>
      </author>
      <author>
        <name>Piccirillo, Jay F</name>
      </author>
      <author>
        <name>Pien, Grace W</name>
      </author>
    </item>
    <item>
      <title>Revisiting laminin and extracellular matrix remodeling in metastatic squamous cell carcinoma: What have we learned after more than four decades of research?</title>
      <link>https://escholarship.org/uc/item/9pp2q1k0</link>
      <description>Patients with squamous cell carcinoma (SCC) have significantly lower survival upon the development of distant metastases. The extracellular matrix (ECM) is a consistent yet dynamic influence on the metastatic capacity of SCCs. The ECM encompasses a milieu of structural proteins, signaling molecules, and enzymes. Just over 40 years ago, the fibrous ECM glycoprotein laminin was identified. Roughly four decades of research have revealed a pivotal role of laminins in metastasis. However, trends in ECM alterations in some cancers have been applied broadly to all metastatic diseases, despite evidence that these characteristics vary by tumor type. We will summarize how laminins influence the SCC metastatic process exclusively. Enhanced laminin protein deposition occurs at the invasive edge of SCC tumors, which correlates with elevated levels of laminin-binding β1 integrins on SCC cells, increased MMP-3 presence, worse prognosis, and lymphatic dissemination. Although these findings are...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9pp2q1k0</guid>
      <pubDate>Fri, 5 Jan 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Aleman, John D</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
      <author>
        <name>Wang, Xiao‐Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma</title>
      <link>https://escholarship.org/uc/item/2x35n54w</link>
      <description>OBJECTIVES: In an evolving era of immunotherapeutic options for persistent or recurrent laryngeal squamous cell carcinoma (LSCC), there is a need for improved biomarkers of treatment response and survival to inform optimal treatment selection and prognostication. Herein, our primary objective was to explore correlations between tumor infiltrating lymphocytes (TILs) and PD-L1 Combined Positive Score (CPS). Secondarily, we sought to explore their combined association with survival outcomes in patients with persistent or recurrent LSCC treated with salvage surgery.
MATERIALS AND METHODS: This was a retrospective cohort study at a single academic medical center. Immunohistochemistry staining for TILs and PD-L1 was performed on a tissue microarray of persistent or recurrent LSCC pathologic specimens. Correlations between TIL subsets and PD-L1 CPS were examined using Pearson's correlation coefficient and survival outcomes were analyzed with the Kaplan-Meier method and log-rank tests.
RESULTS:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2x35n54w</guid>
      <pubDate>Fri, 8 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Smith, Joshua D</name>
      </author>
      <author>
        <name>Bellile, Emily L</name>
      </author>
      <author>
        <name>Ellsperman, Susan E</name>
      </author>
      <author>
        <name>Heft-Neal, Molly E</name>
      </author>
      <author>
        <name>Mann, Jacqueline E</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Hoesli, Rebecca C</name>
      </author>
      <author>
        <name>Swiecicki, Paul L</name>
      </author>
      <author>
        <name>Worden, Francis P</name>
      </author>
      <author>
        <name>Schonewolf, Caitlin</name>
      </author>
      <author>
        <name>Shah, Jennifer L</name>
      </author>
      <author>
        <name>Mierzwa, Michelle L</name>
      </author>
      <author>
        <name>Rosko, Andrew J</name>
      </author>
      <author>
        <name>Stucken, Chaz L</name>
      </author>
      <author>
        <name>Chinn, Steven B</name>
      </author>
      <author>
        <name>Shuman, Andrew G</name>
      </author>
      <author>
        <name>Casper, Keith A</name>
      </author>
      <author>
        <name>Malloy, Kelly M</name>
      </author>
      <author>
        <name>Prince, Mark EP</name>
      </author>
      <author>
        <name>Wolf, Gregory T</name>
      </author>
      <author>
        <name>Thomas, Dafydd G</name>
      </author>
      <author>
        <name>McHugh, Jonathan B</name>
      </author>
      <author>
        <name>Brenner, J Chad</name>
      </author>
      <author>
        <name>Spector, Matthew E</name>
      </author>
    </item>
    <item>
      <title>Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies</title>
      <link>https://escholarship.org/uc/item/9x12q4rp</link>
      <description>Combined TGFβ/PD-L1 inhibition is currently undergoing clinical trials in multiple cancer types. The early reported clinical trials of bintrafusp alfa, a bifunctional fusion protein targeting both of these pathways, have had mixed results. Here, we briefly review recent preclinical advances that can be used to refine these ongoing clinical trials and improve their outcomes.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9x12q4rp</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Strait, Alexander A</name>
      </author>
      <author>
        <name>Wang, Xiao‐Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells</title>
      <link>https://escholarship.org/uc/item/9x0450fh</link>
      <description>In many mouse models of skin cancer, only a few tumors typically form even though many cells competent for tumorigenesis receive the same oncogenic stimuli. These observations suggest an active selection process for tumor-initiating cells. Here, we use quantitative mRNA- and miR-Seq to determine the impact of Hras(G12V) on the transcriptome of keratinocytes. We discover that microRNA-203 is downregulated by Hras(G12V). Using a knockout mouse model, we demonstrate that loss of microRNA-203 promotes selection and expansion of tumor-initiating cells. Conversely, restoration of microRNA-203 using an inducible model potently inhibits proliferation of these cells. We comprehensively identify microRNA-203 targets required for Hras-initiated tumorigenesis. These targets include critical regulators of the Ras pathway and essential genes required for cell division. This study establishes a role for the loss of microRNA-203 in promoting selection and expansion of Hras mutated cells and identifies...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9x0450fh</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Riemondy, Kent</name>
      </author>
      <author>
        <name>Wang, Xiao-jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Torchia, Enrique C</name>
      </author>
      <author>
        <name>Roop, Dennis R</name>
      </author>
      <author>
        <name>Yi, Rui</name>
      </author>
    </item>
    <item>
      <title>Cancer-Associated Fibroblasts Facilitate Squamous Cell Carcinoma Lung Metastasis in Mice by Providing TGFβ-Mediated Cancer Stem Cell Niche</title>
      <link>https://escholarship.org/uc/item/9wx3332x</link>
      <description>Cancer-associated fibroblasts (CAFs) have been shown to enhance squamous cell carcinoma (SCC) growth, but it is unclear whether they promote SCC lung metastasis. We generated CAFs from &lt;i&gt;K15.KrasG12D.Smad4&lt;sup&gt;-/-&lt;/sup&gt;&lt;/i&gt; mouse SCCs. RNA expression analyses demonstrated that CAFs had enriched transforming growth factor-beta (TGFβ) signaling compared to normal tissue-associated fibroblasts (NAFs), therefore we assessed how TGFβ-enriched CAFs impact SCC metastasis. We co-injected SCC cells with CAFs to the skin, tail vein, or the lung to mimic sequential steps of lung metastasis. CAFs increased SCC volume only in lung co-transplantations, characterized with increased proliferation and angiogenesis and decreased apoptosis compared to NAF co-transplanted SCCs. These CAF effects were attenuated by a clinically relevant TGFβ receptor inhibitor, suggesting that CAFs facilitated TGFβ-dependent SCC cell seeding and survival in the lung. CAFs also increased tumor volume when co-transplanted...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9wx3332x</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Shi, Xueke</name>
      </author>
      <author>
        <name>Luo, Jingjing</name>
      </author>
      <author>
        <name>Weigel, Kelsey J</name>
      </author>
      <author>
        <name>Hall, Spencer C</name>
      </author>
      <author>
        <name>Du, Danfeng</name>
      </author>
      <author>
        <name>Wu, Fanglong</name>
      </author>
      <author>
        <name>Rudolph, Michael C</name>
      </author>
      <author>
        <name>Zhou, Hongmei</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Topical Application of Tat-Rac1 Promotes Cutaneous Wound Healing in Normal and Diabetic Mice</title>
      <link>https://escholarship.org/uc/item/9r93831z</link>
      <description>The endogenous small GTPase, Rac1, plays a critical role during normal skin wound healing. It remains to be determined whether endogenous Rac1 can be appropriately activated in chronic wounds; if not, whether exogenous Rac1 has therapeutic effects on wound healing. Here we show that Rac1 protein levels were lower in wounds of db/db diabetic mice than wounds in wild type mice during the healing process. To assess the therapeutic potential of exogenous Rac1 in wound healing, we produced a Tat-Rac1 fusion protein that enters into cells through protein transduction. Tat-Rac1 increased proliferation and migration of keratinocytes and dermal fibroblasts &lt;i&gt;in vitro&lt;/i&gt;. Topical application of Tat-Rac1 accelerated cutaneous wound closure &lt;i&gt;in vivo&lt;/i&gt; in db/db mice as well as wild type mice. Further analyses revealed that Tat-Rac1 had faster re-epithelialization, higher keratinocyte proliferation and migration without an earlier onset of myofibroblast activation than vehicle treated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9r93831z</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Fan, Bin</name>
      </author>
      <author>
        <name>Wang, Tao</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Jian, Zhe</name>
      </author>
      <author>
        <name>Wang, Dongyan D</name>
      </author>
      <author>
        <name>Li, Fulun</name>
      </author>
      <author>
        <name>Wu, Fanglong</name>
      </author>
      <author>
        <name>Bai, Tao</name>
      </author>
      <author>
        <name>Zhang, Gongyi</name>
      </author>
      <author>
        <name>Muller, Nik</name>
      </author>
      <author>
        <name>Holwerda, Barry</name>
      </author>
      <author>
        <name>Han, Gangwen</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas</title>
      <link>https://escholarship.org/uc/item/9h62n395</link>
      <description>Members of the Eph family of receptor tyrosine kinases have been implicated in a wide array of human cancers. The EphB4 receptor is ubiquitously expressed in head and neck squamous cell carcinoma (HNSCC) and has been shown to impart tumorigenic and invasive characteristics to these cancers. In this study, we investigated whether EphB4 receptor targeting can enhance the radiosensitization of HNSCC. Our data show that EphB4 is expressed at high to moderate levels in HNSCC cell lines and patient-derived xenograft (PDX) tumors. We observed decreased survival fractions in HNSCC cells following EphB4 knockdown in clonogenic assays. An enhanced G2 cell cycle arrest with activation of DNA damage response pathway and increased apoptosis was evident in HNSCC cells following combined EphB4 downregulation and radiation compared to EphB4 knockdown and radiation alone. Data using HNSCC PDX models showed significant reduction in tumor volume and enhanced delay in tumor regrowth following sEphB4-HSA...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9h62n395</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Bhatia, Shilpa</name>
      </author>
      <author>
        <name>Hirsch, Kellen</name>
      </author>
      <author>
        <name>Sharma, Jaspreet</name>
      </author>
      <author>
        <name>Oweida, Ayman</name>
      </author>
      <author>
        <name>Griego, Anastacia</name>
      </author>
      <author>
        <name>Keysar, Stephen</name>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
      <author>
        <name>Raben, David</name>
      </author>
      <author>
        <name>Krasnoperov, Valery</name>
      </author>
      <author>
        <name>Gill, Parkash S</name>
      </author>
      <author>
        <name>Pasquale, Elena B</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
    </item>
    <item>
      <title>Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8 + T Cells co-expressing PD-1 and LAG-3 inhibitory receptors</title>
      <link>https://escholarship.org/uc/item/9395s0nm</link>
      <description>Squamous cell carcinoma (SCC) is the second commonest type of skin cancer. Moreover, about 90% of head and neck cancers are SCCs. SCCs develop at a significantly higher rate under chronic immunosuppressive conditions, implicating a role of immune surveillance in controlling SCCs. It remains largely unknown how SCCs evade immune recognition. Here, we established a mouse model by injecting tumor cells derived from primary SCCs harboring KrasG12D mutation and Smad4 deletion into wild-type (wt) or CD8-/- recipients. We found comparable tumor growth between wt and CD8-/- recipients, indicating a complete escape of CD8+ T cell-mediated anti-tumor responses by these SCCs. Mechanistically, CD8+ T cells apparently were not defective in infiltrating tumors given their relatively increased percentage among tumor infiltrating lymphocytes (TILs). CD8+ TILs exhibited phenotypes of chronic activation and exhaustion, including overexpression of activation markers, co-expression of programmed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9395s0nm</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Mishra, Ameet K</name>
      </author>
      <author>
        <name>Kadoishi, Tanya</name>
      </author>
      <author>
        <name>Wang, Xiaoguang</name>
      </author>
      <author>
        <name>Driver, Emily</name>
      </author>
      <author>
        <name>Chen, Zhangguo</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Wang, Jing H</name>
      </author>
    </item>
    <item>
      <title>Smad7 Ameliorates TGF-β–Mediated Skin Inflammation and Associated Wound Healing Defects but Not Susceptibility to Experimental Skin Carcinogenesis</title>
      <link>https://escholarship.org/uc/item/8qp3b49r</link>
      <description>We assessed the roles of Smad7 in skin inflammation and wound healing using genetic and pharmacological approaches. In K5.TGFβ1/K5.Smad7 bigenic (double transgenic) mice, Smad7 transgene expression reversed transforming growth factor (TGF)-β1 transgene-induced inflammation, fibrosis, and subsequent epidermal hyperplasia and molecularly abolished TGF-β and NF-κB activation. Next, we produced recombinant human Smad7 protein with a Tat-tag (Tat-Smad7) that rapidly enters cells. Subcutaneous injection of Tat-Smad7 attenuated infiltration of F4/80&lt;sup&gt;+&lt;/sup&gt; and CD11b&lt;sup&gt;+&lt;/sup&gt; leukocytes and α-smooth muscle actin&lt;sup&gt;+&lt;/sup&gt; fibroblasts before attenuating epidermal hyperplasia in K5.TGFβ1 skin. Furthermore, topically applied Tat-Smad7 on K5.TGFβ1 skin wounds accelerated wound closure, with improved re-epithelialization and reductions in inflammation and fibrotic response. A short treatment with Tat-Smad7 was also sufficient to reduce TGF-β and NF-κB signaling in K5.TGFβ1 skin and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8qp3b49r</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Li, Fulun</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Iriyama, Shunsuke</name>
      </author>
      <author>
        <name>Jian, Zhe</name>
      </author>
      <author>
        <name>Fan, Bin</name>
      </author>
      <author>
        <name>Luo, Jingjing</name>
      </author>
      <author>
        <name>Wang, Dongyan D</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Han, Gangwen</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice</title>
      <link>https://escholarship.org/uc/item/8bv6609v</link>
      <description>BACKGROUND: Oral squamous cell carcinoma (OSCC) is a devastating disease most often associated with tobacco consumption that induces a field of mutations from which a tumor arises. Identification of ways to prevent the emergence of cancer in high-risk patients is an ultimate goal for combatting all types of cancer, including OSCC.
METHODS: Our study employs a mouse model of tongue carcinogenesis induced by tobacco carcinogen mimetic, 4-nitroquinoline 1-oxide (4NQO), to establish tongue dysplasia and OSCC. We use conventional histology, immunohistochemistry, multispectral imaging, mass cytometry, novel cell lines, pharmaceutical inhibition of PI3Kγ, T-cell suppression assays and mouse transplant models in our functional experimentation.
RESULTS: In our study, we identify Ly6G+ granulocytes as the most abundant immune cell type in a model of tongue carcinogenesis induced by tobacco carcinogen mimetic 4NQO. Targeting Ly6G+ granulocytes with a pharmacologic inhibitor of PI3Kγ, an...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8bv6609v</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Nguyen, Khoa A</name>
      </author>
      <author>
        <name>DePledge, Lisa N</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Ke, Yao</name>
      </author>
      <author>
        <name>Samedi, Von</name>
      </author>
      <author>
        <name>Berning, Amber A</name>
      </author>
      <author>
        <name>Owens, Philip</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
    </item>
    <item>
      <title>Head and Neck Cancer Stem Cells</title>
      <link>https://escholarship.org/uc/item/7zm5b7mh</link>
      <description>Head and neck squamous cell carcinoma (HNSCC) is the most common form of head and neck cancer. Annually, more than half a million individuals are diagnosed with this devastating disease, with increasing incidence in Europe and Southeast Asia. The diagnosis of HNSCC often occurs in late stages of the disease and is characterized by manifestation of a high-grade primary tumor and/or lymph node metastasis, precluding timely management of this deadly cancer. Recently, HNSCC cancer stem cells have emerged as an important factor for cancer initiation and maintenance of tumor bulk. Like normal stem cells, cancer stem cells can undergo self-renewal and differentiation. This unique trait allows for maintenance of the cancer stem cell pool and facilitates differentiation into heterogeneous neoplastic progeny when necessary. Recent studies have suggested coexistence of different cancer stem cell populations within a tumor mass, where the tumor initiation and metastasis properties of these...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7zm5b7mh</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Dionne, LK</name>
      </author>
      <author>
        <name>Driver, ER</name>
      </author>
      <author>
        <name>Wang, XJ</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer</title>
      <link>https://escholarship.org/uc/item/7v1900wh</link>
      <description>In this report, we describe in detail the evolving procedures to optimize humanized mouse cohort generation, including optimal conditioning, choice of lineage for engraftment, threshold for successful engraftment, HNSCC tumor implantation, and immune and stroma cell analyses. We developed a dual infusion protocol of human hematopoietic stem and progenitor cells (HSPCs) and mesenchymal stem cells (MSCs), leading to incremental human bone marrow engraftment, and exponential increase in mature peripheral human immune cells, and intratumor homing that includes a more complete lineage reconstitution. Additionally, we have identified practical rules to predict successful HSPC/MSC expansion, and a peripheral human cell threshold associated with bone marrow engraftment, both of which will optimize cohort generation and management. The tremendous advances in immune therapy in cancer have made the need for appropriate and standardized models more acute than ever, and therefore, we anticipate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7v1900wh</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Morton, John J</name>
      </author>
      <author>
        <name>Keysar, Stephen B</name>
      </author>
      <author>
        <name>Perrenoud, Loni</name>
      </author>
      <author>
        <name>Chimed, Tugs‐Saikhan</name>
      </author>
      <author>
        <name>Reisinger, Julie</name>
      </author>
      <author>
        <name>Jackson, Brian</name>
      </author>
      <author>
        <name>Le, Phuong N</name>
      </author>
      <author>
        <name>Nieto, Cera</name>
      </author>
      <author>
        <name>Gomez, Karina</name>
      </author>
      <author>
        <name>Miller, Bettina</name>
      </author>
      <author>
        <name>Gao, Dexiang</name>
      </author>
      <author>
        <name>Somerset, Hilary</name>
      </author>
      <author>
        <name>Wang, Xiao‐Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
    </item>
    <item>
      <title>Ephrin‐B2 overexpression predicts for poor prognosis and response to therapy in solid tumors</title>
      <link>https://escholarship.org/uc/item/7h2680kb</link>
      <description>Ephrin B2 is variably expressed on tumor cells and its blockade has been shown to inhibit angiogenesis in animal models of pancreatic, colorectal, lung and head, and neck squamous cell carcinomas. However, the implications of ephrinB2 expression in cancer patients have remained elusive. In this study, we analyzed the cancer genome atlas (TCGA) for ephrinB2 expression. We report significant correlations between EFNB2 expression, overall survival and disease-free survival in head and neck squamous cell carcinoma (HNSCC, n = 519), pancreatic adenocarcinoma (n = 186), and bladder urothelial carcinoma (n = 410). In HNSCC patients, high-EFNB2 mRNA expression was associated with tumor HPV negativity, oral cavity location, alcohol intake, higher TP53 mutation, and EGFR amplification. EphrinB2 overexpression also correlated with worse response to chemotherapy and radiotherapy. The therapeutic potential of blocking ephrinB2 was validated in HNSCC patient-derived tumor xenografts and showed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7h2680kb</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Oweida, Ayman</name>
      </author>
      <author>
        <name>Bhatia, Shilpa</name>
      </author>
      <author>
        <name>Hirsch, Kellen</name>
      </author>
      <author>
        <name>Calame, Dylan</name>
      </author>
      <author>
        <name>Griego, Anastacia</name>
      </author>
      <author>
        <name>Keysar, Steve</name>
      </author>
      <author>
        <name>Pitts, Todd</name>
      </author>
      <author>
        <name>Sharma, Jaspreet</name>
      </author>
      <author>
        <name>Eckhardt, Gail</name>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
      <author>
        <name>Wang, Xiao Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Parkash, Gill</name>
      </author>
      <author>
        <name>Califano, Joseph</name>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
    </item>
    <item>
      <title>Inhibition of EphB4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers</title>
      <link>https://escholarship.org/uc/item/7ck792jw</link>
      <description>Identifying targets present in the tumor microenvironment that contribute to immune evasion has become an important area of research. In this study, we identified EphB4-ephrin-B2 signaling as a regulator of both innate and adaptive components of the immune system. EphB4 belongs to receptor tyrosine kinase family that interacts with ephrin-B2 ligand at sites of cell-cell contact, resulting in bidirectional signaling. We found that EphB4-ephrin-B2 inhibition alone or in combination with radiation (RT) reduced intratumoral regulatory T cells (Tregs) and increased activation of both CD8&lt;sup&gt;+&lt;/sup&gt; and CD4&lt;sup&gt;+&lt;/sup&gt;Foxp3&lt;sup&gt;-&lt;/sup&gt; T cells compared with the control group in an orthotopic head and neck squamous cell carcinoma (HNSCC) model. We also compared the effect of EphB4-ephrin-B2 inhibition combined with RT with combined anti-PDL1 and RT and observed similar tumor growth suppression, particularly at early time-points. A patient-derived xenograft model showed reduction of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7ck792jw</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Bhatia, Shilpa</name>
      </author>
      <author>
        <name>Oweida, Ayman</name>
      </author>
      <author>
        <name>Lennon, Shelby</name>
      </author>
      <author>
        <name>Darragh, Laurel B</name>
      </author>
      <author>
        <name>Milner, Dallin</name>
      </author>
      <author>
        <name>Phan, Andy V</name>
      </author>
      <author>
        <name>Mueller, Adam C</name>
      </author>
      <author>
        <name>Van Court, Benjamin</name>
      </author>
      <author>
        <name>Raben, David</name>
      </author>
      <author>
        <name>Serkova, Natalie J</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
      <author>
        <name>Clambey, Eric T</name>
      </author>
      <author>
        <name>Pasquale, Elena B</name>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
    </item>
    <item>
      <title>IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin</title>
      <link>https://escholarship.org/uc/item/78h359j6</link>
      <description>Establishment of a permissive pre-malignant niche in concert with mutant stem are key triggers to initiate skin carcinogenesis. An understudied area of research is finding upstream regulators of both these triggers. IL27, a pleiotropic cytokine with both pro- and anti-inflammatory properties, was found to be a key regulator of both. Two step skin carcinogenesis model and K15-KRASG12D mouse model were used to understand the role of IL27 in skin tumors. CD11b-/- mice and small-molecule of ETAR signaling (ZD4054) inhibitor were used in vivo to understand mechanistically how IL27 promotes skin carcinogenesis. Interestingly, using in vivo studies, IL27 promoted papilloma incidence primarily through IL27 signaling in bone-marrow derived cells. Mechanistically, IL27 initiated the establishment of the pre-malignant niche and expansion of mutated stem cells in K15-KRASG12D mouse model by driving the accumulation of Endothelin A receptor (ETAR)-positive CD11b cells in the skin-a novel category...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/78h359j6</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Dibra, Denada</name>
      </author>
      <author>
        <name>Mitra, Abhisek</name>
      </author>
      <author>
        <name>Newman, Melissa</name>
      </author>
      <author>
        <name>Xia, Xueqing</name>
      </author>
      <author>
        <name>Keenan, Camille</name>
      </author>
      <author>
        <name>Cutrera, Jeffry J</name>
      </author>
      <author>
        <name>Mathis, J Michael</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Myers, Jeffrey</name>
      </author>
      <author>
        <name>Li, Shulin</name>
      </author>
    </item>
    <item>
      <title>Cancer Stem Cells in Squamous Cell Carcinoma</title>
      <link>https://escholarship.org/uc/item/6xd4r8kx</link>
      <description>Cancer stem cells (CSCs) are found in many cancer types, including squamous cell carcinoma (SCC). CSCs initiate cancer formation and are linked to metastasis and resistance to therapies. Studies have revealed that several distinct CSC populations coexist in SCC and that tumor initiation and metastatic potential of these populations can be uncoupled. Therefore, it is critical to understand CSC biology to develop novel CSC-targeted therapies for patients with SCC with poor prognoses. This review compares the properties of CSCs in SCC with normal stem cells in the skin, summarizes current advances and characteristics of CSCs, and considers the challenges for CSC-targeted treatment of SCC.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6xd4r8kx</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Jian, Zhe</name>
      </author>
      <author>
        <name>Strait, Alexander</name>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model</title>
      <link>https://escholarship.org/uc/item/6t26x864</link>
      <description>BackgroundMembers of the Eph/ephrin gene families act as key regulators of cerebellar development during embryogenesis. Aberrant signaling of Eph family of receptor tyrosine kinases and their ephrin ligands has also been implicated in human cancers. Medulloblastoma is an aggressive primitive neuroectodermal tumor that originates from granule neuron precursors in the cerebellum. Previous studies have suggested a role for the ephrin-A5 ligand and its receptors, EphA4 and EphA7, in granule cell-precursor formation and in guiding cell migration. In the present study, we investigated the effects of genetic loss of ephrin-A5, EphA4, and EphA7 on the spatiotemporal development of medulloblastoma tumors in the context of the smoothened transgenic mouse model system.FindingsRadiographic magnetic resonance imaging (MRI) was performed to monitor tumor growth in a genetically engineered mouse model of medulloblastoma. Tumor tissue was harvested to determine changes in the expression of phosphorylated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6t26x864</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Bhatia, Shilpa</name>
      </author>
      <author>
        <name>Hirsch, Kellen</name>
      </author>
      <author>
        <name>Baig, Nimrah A</name>
      </author>
      <author>
        <name>Rodriguez, Olga</name>
      </author>
      <author>
        <name>Timofeeva, Olga</name>
      </author>
      <author>
        <name>Kavanagh, Kevin</name>
      </author>
      <author>
        <name>Lee, Yi Chien</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Albanese, Christopher</name>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
    </item>
    <item>
      <title>Midbody: from cellular junk to regulator of cell polarity and cell fate</title>
      <link>https://escholarship.org/uc/item/6dj4t6mb</link>
      <description>At late mitosis, the mother cell divides by the formation of a cleavage furrow, leaving two daughter cells connected by a thin intercellular bridge. During ingression of the cleavage furrow, the central spindle microtubules are compacted to form the structure known as the midbody (MB). The MB is situated within the intercellular bridge, with the abscission site sometimes occurring on one side of the MB. As a result of this one-sided (asymmetric) abscission, only one daughter cell can inherit the post-mitotic MB. Interestingly, recent studies have identified post-mitotic MBs as novel signaling platforms regulating stem cell fate and proliferation. Additionally, MBs were proposed to serve a role of polarity cues during the neurite outgrowth and apical lumen formation. Thus, abscission and MB inheritance is clearly a highly regulated cellular event that can affect development and various other cellular functions. In this review we discuss the latest findings regarding post-mitotic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6dj4t6mb</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Dionne, Lai Kuan</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Prekeris, Rytis</name>
      </author>
    </item>
    <item>
      <title>Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma</title>
      <link>https://escholarship.org/uc/item/64k4t9k6</link>
      <description>Squamous cell carcinoma (SCC) is the second commonest type of skin cancer, and SCCs make up about 90% of head and neck cancers (HNSCCs). HNSCCs harbor two frequent molecular alterations, namely, gain-of-function alterations of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (&lt;i&gt;PIK3CA)&lt;/i&gt; and loss-of-function mutations of tumor protein p53 (&lt;i&gt;TP53&lt;/i&gt;). However, it remains poorly understood whether HNSCCs harboring different genetic alterations exhibit differential immune tumor microenvironments (TME). It also remains unknown whether &lt;i&gt;PIK3CA&lt;/i&gt; hyperactivation and &lt;i&gt;TP53&lt;/i&gt; deletion can lead to SCC development spontaneously. Here, we analyzed the Cancer Genome Atlas (TCGA) datasets of HNSCCs and found that patients with both &lt;i&gt;PIK3CA&lt;/i&gt; and &lt;i&gt;TP53&lt;/i&gt; alterations exhibited worse survival, significantly lower CD8 tumor infiltrating lymphocytes (TILs) and higher M0 macrophages than other controls. To better model human tumorigenesis, we deleted &lt;i&gt;TP53&lt;/i&gt;...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/64k4t9k6</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Samantha MY</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Nicklawsky, Andrew G</name>
      </author>
      <author>
        <name>Krinsky, Alexandra L</name>
      </author>
      <author>
        <name>Brunetti, Tonya</name>
      </author>
      <author>
        <name>Woolaver, Rachel A</name>
      </author>
      <author>
        <name>Wang, Xiaoguang</name>
      </author>
      <author>
        <name>Chen, Zhangguo</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Gao, Dexiang</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Wang, Jing H</name>
      </author>
    </item>
    <item>
      <title>The role of Smad7 in oral mucositis</title>
      <link>https://escholarship.org/uc/item/62g5z0k0</link>
      <description>Oral mucositis, a severe oral ulceration, is a common toxic effect of radio- or chemoradio-therapy and a limiting factor to using the maximum dose of radiation for effective cancer treatment. Among cancer patients, at least 40% and up to 70%, of individuals treated with standard chemotherapy regimens or upper-body radiation, develop oral mucositis. To date, there is no FDA approved drug to treat oral mucositis in cancer patients. The key challenges for oral mucositis treatment are to repair and protect ulcerated oral mucosa without promoting cancer cell growth. Oral mucositis is the result of complex, multifaceted pathobiology, involving a series of signaling pathways and a chain of interactions between the epithelium and submucosa. Among those pathways and interactions, the activation of nuclear factor-kappa B (NF-κB) is critical to the inflammation process of oral mucositis. We recently found that activation of TGFβ (transforming growth factor β) signaling is associated with...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/62g5z0k0</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Han, Gangwen</name>
      </author>
      <author>
        <name>Zhao, Carolyn W</name>
      </author>
      <author>
        <name>Garl, Pamela J</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC</title>
      <link>https://escholarship.org/uc/item/5vk2c1rg</link>
      <description>The implementation of cancer immunotherapies has seen limited clinical success in head and neck squamous cell carcinoma (HNSCC). Interleukin-2 (IL-2), which modulates the survival and functionality of lymphocytes, is an attractive target for new immunotherapies but one that is limited by presence of regulatory T&amp;nbsp;cells (Tregs) expressing the high-affinity IL-2Rα. The bispecific immunocytokine PD1-IL2v preferentially delivers IL-2 signaling through IL-2Rβγ on PD-1-expressing cells. Selectively targeting the intermediate-affinity IL-2Rβγ can be leveraged to induce anti-tumor immune responses in effector T&amp;nbsp;cells and natural killer (NK) cells while limiting the negative regulation of IL-2Rα activation on Tregs. Using radiation therapy (RT) in combination with PD1-IL2v improves local tumor control and survival, and controls metastatic spread in orthotopic HNSCC tumor models. PD1-IL2v drives systemic activation and expansion of circulating and tumor-infiltrating cytotoxic T&amp;nbsp;cells...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5vk2c1rg</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Gadwa, Jacob</name>
      </author>
      <author>
        <name>Amann, Maria</name>
      </author>
      <author>
        <name>Bickett, Thomas E</name>
      </author>
      <author>
        <name>Knitz, Michael W</name>
      </author>
      <author>
        <name>Darragh, Laurel B</name>
      </author>
      <author>
        <name>Piper, Miles</name>
      </author>
      <author>
        <name>Van Court, Benjamin</name>
      </author>
      <author>
        <name>Bukkapatnam, Sanjana</name>
      </author>
      <author>
        <name>Pham, Tiffany T</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Saviola, Anthony J</name>
      </author>
      <author>
        <name>Deak, Laura Codarri</name>
      </author>
      <author>
        <name>Umaña, Pablo</name>
      </author>
      <author>
        <name>Klein, Christian</name>
      </author>
      <author>
        <name>D'Alessandro, Angelo</name>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
    </item>
    <item>
      <title>Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2</title>
      <link>https://escholarship.org/uc/item/5sm9s4wd</link>
      <description>Background: We have an incomplete understanding of the differences between cancer stem cells (CSCs) in human papillomavirus-positive (HPV-positive) and -negative (HPV-negative) head and neck squamous cell cancer (HNSCC). The PI3K pathway has the most frequent activating genetic events in HNSCC (especially HPV-positive driven), but the differential signaling between CSCs and non-CSCs is also unknown.
Methods: We addressed these unresolved questions using CSCs identified from 10 HNSCC patient-derived xenografts (PDXs). Sored populations were serially passaged in nude mice to evaluate tumorigenicity and tumor recapitulation. The transcription profile of HNSCC CSCs was characterized by mRNA sequencing, and the susceptibility of CSCs to therapy was investigated using an in vivo model. SOX2 transcriptional activity was used to follow the asymmetric division of PDX-derived CSCs. All statistical tests were two-sided.
Results: CSCs were enriched by high aldehyde dehydrogenase (ALDH) activity...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5sm9s4wd</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Keysar, Stephen B</name>
      </author>
      <author>
        <name>Le, Phuong N</name>
      </author>
      <author>
        <name>Miller, Bettina</name>
      </author>
      <author>
        <name>Jackson, Brian C</name>
      </author>
      <author>
        <name>Eagles, Justin R</name>
      </author>
      <author>
        <name>Nieto, Cera</name>
      </author>
      <author>
        <name>Kim, Jihye</name>
      </author>
      <author>
        <name>Tang, Binwu</name>
      </author>
      <author>
        <name>Glogowska, Magdalena J</name>
      </author>
      <author>
        <name>Morton, J Jason</name>
      </author>
      <author>
        <name>Padilla-Just, Nuria</name>
      </author>
      <author>
        <name>Gomez, Karina</name>
      </author>
      <author>
        <name>Warnock, Emily</name>
      </author>
      <author>
        <name>Reisinger, Julie</name>
      </author>
      <author>
        <name>Arcaroli, John J</name>
      </author>
      <author>
        <name>Messersmith, Wells A</name>
      </author>
      <author>
        <name>Wakefield, Lalage M</name>
      </author>
      <author>
        <name>Gao, Dexiang</name>
      </author>
      <author>
        <name>Tan, Aik-Choon</name>
      </author>
      <author>
        <name>Serracino, Hilary</name>
      </author>
      <author>
        <name>Vasiliou, Vasilis</name>
      </author>
      <author>
        <name>Roop, Dennis R</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
    </item>
    <item>
      <title>Macrophages Promote Growth of Squamous Cancer Independent of T cells</title>
      <link>https://escholarship.org/uc/item/5gr4m65x</link>
      <description>Oral cancers, primarily squamous cell carcinomas (SCCs), progress either slowly or aggressively. Here we assessed the role of macrophages in SCC behavior. We used mouse SCC cells derived from tumors harboring a Kras&lt;sup&gt;G12D&lt;/sup&gt; activation mutation and Smad4 deletion in keratin 15-positive stem cells and a human oral SCC cell line, FaDu, which has &lt;i&gt;NRAS&lt;/i&gt; amplification and &lt;i&gt;SMAD4&lt;/i&gt; deletion. SCC cells were transplanted into immune-compromised or immune-competent (syngeneic) recipients. After tumors were established, we used clodronate liposomes to ablate macrophages. We found that the number of tumor-associated macrophages (TAMs) was not affected by the presence of T cells but differed considerably among tumors derived from different SCC lines. Clodronate significantly reduced TAMs and splenic macrophages, resulting in reduced SCC volumes. Tumors with clodronate treatment did not show decreased proliferation but did exhibit increased apoptosis and reduced vascular density....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5gr4m65x</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Wu, FL</name>
      </author>
      <author>
        <name>Nolan, K</name>
      </author>
      <author>
        <name>Strait, AA</name>
      </author>
      <author>
        <name>Bian, L</name>
      </author>
      <author>
        <name>Nguyen, KA</name>
      </author>
      <author>
        <name>Wang, JH</name>
      </author>
      <author>
        <name>Jimeno, A</name>
      </author>
      <author>
        <name>Zhou, HM</name>
      </author>
      <author>
        <name>Young, CD</name>
      </author>
      <author>
        <name>Wang, XJ</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts</title>
      <link>https://escholarship.org/uc/item/5cb205hj</link>
      <description>Transforming growth factor-β (TGF-β) signaling is essential in embryo development and maintaining normal homeostasis. Extensive evidence shows that TGF-β activation acts on several cell types, including epithelial cells, fibroblasts, and immune cells, to form a pro-fibrotic environment, ultimately leading to fibrotic diseases. TGF-β is stored in the matrix in a latent form; once activated, it promotes a fibroblast to myofibroblast transition and regulates extracellular matrix (ECM) formation and remodeling in fibrosis. TGF-β signaling can also promote cancer progression through its effects on the tumor microenvironment. In cancer, TGF-β contributes to the generation of cancer-associated fibroblasts (CAFs) that have different molecular and cellular properties from activated or fibrotic fibroblasts. CAFs promote tumor progression and chronic tumor fibrosis via TGF-β signaling. Fibrosis and CAF-mediated cancer progression share several common traits and are closely related. In this...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5cb205hj</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Shi, Xueke</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Zhou, Hongmei</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Hedgehog Signaling Drives Radioresistance and Stroma-Driven Tumor Repopulation in Head and Neck Squamous Cancers</title>
      <link>https://escholarship.org/uc/item/4qf1w094</link>
      <description>Local control and overall survival in patients with advanced head and neck squamous cell cancer (HNSCC) remains dismal. Signaling through the Hedgehog (Hh) pathway is associated with epithelial-to-mesenchymal transition, and activation of the Hh effector transcription factor Gli1 is a poor prognostic factor in this disease setting. Here, we report that increased GLI1 expression in the leading edge of HNSCC tumors is further increased by irradiation, where it contributes to therapeutic inhibition. Hh pathway blockade with cyclopamine suppressed GLI1 activation and enhanced tumor sensitivity to radiotherapy. Furthermore, radiotherapy-induced GLI1 expression was mediated in part by the mTOR/S6K1 pathway. Stroma exposed to radiotherapy promoted rapid tumor repopulation, and this effect was suppressed by Hh inhibition. Our results demonstrate that Gli1 that is upregulated at the tumor-stroma intersection in HNSCC is elevated by radiotherapy, where it contributes to stromal-mediated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4qf1w094</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Gan, Gregory N</name>
      </author>
      <author>
        <name>Eagles, Justin</name>
      </author>
      <author>
        <name>Keysar, Stephen B</name>
      </author>
      <author>
        <name>Wang, Guoliang</name>
      </author>
      <author>
        <name>Glogowska, Magdalena J</name>
      </author>
      <author>
        <name>Altunbas, Cem</name>
      </author>
      <author>
        <name>Anderson, Ryan T</name>
      </author>
      <author>
        <name>Le, Phuong N</name>
      </author>
      <author>
        <name>Morton, J Jason</name>
      </author>
      <author>
        <name>Frederick, Barbara</name>
      </author>
      <author>
        <name>Raben, David</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
    </item>
    <item>
      <title>Grape seed extract and resveratrol prevent 4‐nitroquinoline 1‐oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses</title>
      <link>https://escholarship.org/uc/item/4ks8f110</link>
      <description>Preventive measures against oral carcinogenesis are urgently warranted to lower the high morbidity and mortality associated with this malignancy worldwide. Here, we investigated the chemopreventive efficacy of grape seed extract (GSE) and resveratrol (Res) in 4-nitroquinoline-1-oxide (4NQO)-induced tongue tumorigenesis in C57BL/6 mice. Following 8 weeks of 4NQO exposure (100 µg/ml in drinking water), mice were fed with either control AIN-76A diet or diet containing 0.2% GSE (w/w) or 0.25% Res (w/w) for 8 subsequent weeks, while continued on 4NQO. Upon termination of the study at 16 weeks, tongue tissues were histologically evaluated for hyperplasia, dysplasia, and papillary lesions, and then analyzed for molecular targets by immunohistochemistry. GSE and Res feeding for 8 weeks, moderately decreased the incidence, but significantly prevented the multiplicity and severity of 4NQO-induced preneoplastic and neoplastic lesions, without any apparent toxicity. In tongue tissues, both...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4ks8f110</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Shrotriya, Sangeeta</name>
      </author>
      <author>
        <name>Tyagi, Alpna</name>
      </author>
      <author>
        <name>Deep, Gagan</name>
      </author>
      <author>
        <name>Orlicky, David J</name>
      </author>
      <author>
        <name>Wisell, Joshua</name>
      </author>
      <author>
        <name>Wang, Xiao‐Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Sclafani, Robert A</name>
      </author>
      <author>
        <name>Agarwal, Rajesh</name>
      </author>
      <author>
        <name>Agarwal, Chapla</name>
      </author>
    </item>
    <item>
      <title>Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors</title>
      <link>https://escholarship.org/uc/item/40p8346h</link>
      <description>Non-small-cell lung cancer (NSCLC) is a common malignancy with a poor prognosis. Despite progress targeting oncogenic drivers, there are no therapies targeting tumor-suppressor loss. Smad4 is an established tumor suppressor in pancreatic and colon cancer; however, the consequences of Smad4 loss in lung cancer are largely unknown. We evaluated Smad4 expression in human NSCLC samples and examined Smad4 alterations in large NSCLC data sets and found that reduced Smad4 expression is common in human NSCLC and occurs through a variety of mechanisms, including mutation, homozygous deletion and heterozygous loss. We modeled Smad4 loss in lung cancer by deleting Smad4 in airway epithelial cells and found that Smad4 deletion both initiates and promotes lung tumor development. Interestingly, both Smad4−/− mouse tumors and human NSCLC samples with reduced Smad4 expression demonstrated increased DNA damage, whereas Smad4 knockdown in lung cancer cells reduced DNA repair and increased apoptosis...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/40p8346h</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Haeger, SM</name>
      </author>
      <author>
        <name>Thompson, JJ</name>
      </author>
      <author>
        <name>Kalra, S</name>
      </author>
      <author>
        <name>Cleaver, TG</name>
      </author>
      <author>
        <name>Merrick, D</name>
      </author>
      <author>
        <name>Wang, X-J</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Malkoski, SP</name>
      </author>
    </item>
    <item>
      <title>Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.</title>
      <link>https://escholarship.org/uc/item/3zs9h5cm</link>
      <description>Transforming growth factor β (TGF-β) signaling either promotes or inhibits tumor formation and/or progression of many cancer types including squamous cell carcinoma (SCC). Canonical TGF-β signaling is mediated by a number of downstream proteins including Smad family proteins. Alterations in either TGF-β or Smad signaling can impact cancer. For instance, defects in TGF-β type I and type II receptors (TGF-βRI and TGF-βRII) and in Smad2/3/4 could promote tumor development. Conversely, increased TGF-β1 and activated TGF-βRI and Smad3 have all been shown to have tumor-promoting effects in experimental systems of human and mouse SCCs. Among TGF-β/Smad signaling, only TGF-βRII or Smad4 deletion in mouse epithelium causes spontaneous SCC in the mouse model, highlighting the critical roles of TGF-βRII and Smad4 in tumor suppression. Herein, we review the dual roles of the TGF-β/Smad signaling pathway and related mechanisms in SCC, highlighting the potential benefits and challenges of TGF-β/Smad-targeted...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3zs9h5cm</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Wu, Fanglong</name>
      </author>
      <author>
        <name>Weigel, Kelsey J</name>
      </author>
      <author>
        <name>Zhou, Hongmei</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models</title>
      <link>https://escholarship.org/uc/item/3x00t64k</link>
      <description>BackgroundImmunocompetent animal models are required to study tumor-host interactions, immunotherapy, and immunotherapeutic combinations, however the currently available immunocompetent lung cancer models have substantial limitations. While orthotopic models potentially help fill this gap, the utility of these models has been limited by the very small number of murine lung cancer cell lines capable of forming orthotopic tumors in immunocompetent C57BL/6 hosts.MethodsPrimary lung tumors with specific genetic alterations were created in C57BL/6 background mice. These tumors were then passaged through other animals to increase tumorigenicity and select for the ability to grow in a non-self animal. Once tumors demonstrated growth in a non-self host, cell lines were established. Successful cell lines were evaluated for the ability to produce orthotopic lung tumors in immunocompetent hosts.ResultsWe produced six murine lung cancer lines capable of orthotopic lung tumor formation in...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3x00t64k</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Nolan, Kyle</name>
      </author>
      <author>
        <name>Verzosa, Gregory</name>
      </author>
      <author>
        <name>Cleaver, Tim</name>
      </author>
      <author>
        <name>Tippimanchai, Darinee</name>
      </author>
      <author>
        <name>DePledge, Lisa N</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Young, Christian</name>
      </author>
      <author>
        <name>Le, Anh</name>
      </author>
      <author>
        <name>Doebele, Robert</name>
      </author>
      <author>
        <name>Li, Howard</name>
      </author>
      <author>
        <name>Malkoski, Stephen P</name>
      </author>
    </item>
    <item>
      <title>Therapeutic Intervention Using a Smad7-Based Tat Protein to Treat Radiation-Induced Oral Mucositis</title>
      <link>https://escholarship.org/uc/item/3t34295h</link>
      <description>PURPOSE: Recent studies reported therapeutic effects of Smad7 on oral mucositis in mice without compromising radiation therapy-induced cancer cell killing in neighboring oral cancer. This study aims to assess whether a Smad7-based biologic can treat oral mucositis in a clinically relevant setting by establishing an oral mucositis model in dogs and analyzing molecular targets.
METHODS AND MATERIALS: We created a truncated human Smad7 protein fused with the cell-penetrating Tat tag (Tat-PYC-Smad7). We used intensity modulated radiation therapy to induce oral mucositis in dogs and applied Tat-PYC-Smad7 to the oral mucosa in dose-finding studies after intensity modulated radiation therapy. Clinical outcomes were evaluated. Molecular targets were analyzed in biopsies and serum samples.
RESULTS: Tat-PYC-Smad7 treatment significantly shortened the duration of grade 3 oral mucositis based on double-blinded Veterinary Radiation Therapy Oncology Group scores and histopathology evaluations....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3t34295h</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Boss, Mary-Keara</name>
      </author>
      <author>
        <name>Ke, Yao</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Harrison, Lauren G</name>
      </author>
      <author>
        <name>Lee, Ber-In</name>
      </author>
      <author>
        <name>Prebble, Amber</name>
      </author>
      <author>
        <name>Martin, Tiffany</name>
      </author>
      <author>
        <name>Trageser, Erin</name>
      </author>
      <author>
        <name>Hall, Spencer</name>
      </author>
      <author>
        <name>Wang, Donna D</name>
      </author>
      <author>
        <name>Wang, Suyan</name>
      </author>
      <author>
        <name>Chow, Lyndah</name>
      </author>
      <author>
        <name>Holwerda, Barry</name>
      </author>
      <author>
        <name>Raben, David</name>
      </author>
      <author>
        <name>Regan, Daniel</name>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
      <author>
        <name>Dow, Steven</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Cooperation Between Pten and Smad4 in Murine Salivary Gland Tumor Formation and Progression</title>
      <link>https://escholarship.org/uc/item/3701n5m3</link>
      <description>Salivary gland tumor (SGT) is a rare tumor type, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity. Currently, the molecular mechanisms that cause SGT pathogenesis remain poorly understood. A lack of animal models that faithfully recapitulate the naturally occurring process of human SGTs has hampered research progress on this field. In this report, we developed an inducible keratin 5-driven conditional knockout mouse model to delete gene(s) of interest in murine salivary gland upon local RU486 delivery. We have deleted two major tumor suppressors, Pten, a negative regulator of the PI3K pathway, and Smad4, the central signaling mediator of TGFβ pathway, in the murine salivary gland. Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients. Deletion of both Pten and Smad4 in murine salivary gland developed several malignancies, with salivary adenoid...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3701n5m3</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Cao, Yu</name>
      </author>
      <author>
        <name>Liu, Han</name>
      </author>
      <author>
        <name>Gao, Liwei</name>
      </author>
      <author>
        <name>Lu, Ling</name>
      </author>
      <author>
        <name>Du, Li</name>
      </author>
      <author>
        <name>Bai, Han</name>
      </author>
      <author>
        <name>Li, Jiang</name>
      </author>
      <author>
        <name>Said, Sherif</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Song, John</name>
      </author>
      <author>
        <name>Serkova, Natalie</name>
      </author>
      <author>
        <name>Wei, Minjie</name>
      </author>
      <author>
        <name>Xiao, Jing</name>
      </author>
      <author>
        <name>Lu, Shi-Long</name>
      </author>
    </item>
    <item>
      <title>The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma</title>
      <link>https://escholarship.org/uc/item/35m7f55q</link>
      <description>BACKGROUND: The programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) are validated cancer targets; however, emerging mechanisms and impact of PD-L1 intracellular signaling on cancer behavior are poorly understood.
METHODS: We investigated the cancer cell intrinsic role of PD-L1 in multiple patient-derived models in vitro and in vivo. PD-L1 overexpression, knockdown, and PD-L1 intracellular domain (PD-L1-ICD) deletion (Δ260-290PD-L1) models were assessed for key cancer properties: clonogenicity, motility, invasion, and immune evasion. To determine how PD-L1 transduces signals intracellularly, we used the BioID2 platform to identify the PD-L1 intracellular interactome. Both human papillomavirus-positive and negative patient-derived xenografts were implanted in NOD-scid-gamma and humanized mouse models to investigate the effects of recombinant PD-1, anti-PD-L1, and anti-signal transducer and activator of transcription 3 (STAT3) in vivo.
RESULTS: PD-L1 intracellular...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/35m7f55q</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Nieto, Cera</name>
      </author>
      <author>
        <name>Miller, Bettina</name>
      </author>
      <author>
        <name>Alzofon, Nathaniel</name>
      </author>
      <author>
        <name>Chimed, Tugy</name>
      </author>
      <author>
        <name>Himes, Jack</name>
      </author>
      <author>
        <name>Joshi, Molishree</name>
      </author>
      <author>
        <name>Gomez, Karina</name>
      </author>
      <author>
        <name>Chowdhury, Farshad N</name>
      </author>
      <author>
        <name>Le, Phuong N</name>
      </author>
      <author>
        <name>Weaver, Alice</name>
      </author>
      <author>
        <name>Somerset, Hilary</name>
      </author>
      <author>
        <name>Morton, J Jason</name>
      </author>
      <author>
        <name>Wang, Jing H</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Gao, Dexiang</name>
      </author>
      <author>
        <name>Hansen, Kirk</name>
      </author>
      <author>
        <name>Keysar, Stephen B</name>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
    </item>
    <item>
      <title>Mouse Models for Studying Oral Cancer: Impact in the Era of Cancer Immunotherapy</title>
      <link>https://escholarship.org/uc/item/2w21t3r5</link>
      <description>Model systems for oral cancer research have progressed from tumor epithelial cell cultures to in vivo systems that mimic oral cancer genetics, pathological characteristics, and tumor-stroma interactions of oral cancer patients. In the era of cancer immunotherapy, it is imperative to use model systems to test oral cancer prevention and therapeutic interventions in the presence of an immune system and to discover mechanisms of stromal contributions to oral cancer carcinogenesis. Here, we review in vivo mouse model systems commonly used for studying oral cancer and discuss the impact these models are having in advancing basic mechanisms, chemoprevention, and therapeutic intervention of oral cancer while highlighting recent discoveries concerning the role of immune cells in oral cancer. Improvements to in vivo model systems that highly recapitulate human oral cancer hold the key to identifying features of oral cancer initiation, progression, and invasion as well as molecular and cellular...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2w21t3r5</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Luo, JJ</name>
      </author>
      <author>
        <name>Young, CD</name>
      </author>
      <author>
        <name>Zhou, HM</name>
      </author>
      <author>
        <name>Wang, XJ</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer</title>
      <link>https://escholarship.org/uc/item/2p64k4jk</link>
      <description>&lt;b&gt;Purpose:&lt;/b&gt; Our goal was to evaluate the safety and toxicity of combining a PARP inhibitor, olaparib, with cetuximab and fractionated intensity-modulated radiotherapy for patients with locally advanced head and neck cancer and heavy smoking histories.&lt;b&gt;Patients and Methods:&lt;/b&gt; Patients with ≥10 packs/year history of smoking were treated with olaparib at doses ranging from 25-200 mg orally twice daily beginning approximately 10 days prior to initiation of and with concurrent radiation (69.3 Gy in 33 fractions) using a time-to-event continual reassessment method model. Cetuximab was administered starting approximately 5 days prior to radiation per standard of care.&lt;b&gt;Results:&lt;/b&gt; A total of 16 patients were entered onto the study, with 15 evaluable for acute toxicity. The most common treatment-related grade 3-4 side effects were radiation dermatitis and mucositis (38% and 69%, respectively). The MTD was determined to be 50 mg orally twice daily, but the recommended phase II...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2p64k4jk</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Karam, Sana D</name>
      </author>
      <author>
        <name>Reddy, Krishna</name>
      </author>
      <author>
        <name>Blatchford, Patrick J</name>
      </author>
      <author>
        <name>Waxweiler, Tim</name>
      </author>
      <author>
        <name>DeLouize, Alicia M</name>
      </author>
      <author>
        <name>Oweida, Ayman</name>
      </author>
      <author>
        <name>Somerset, Hilary</name>
      </author>
      <author>
        <name>Marshall, Carrie</name>
      </author>
      <author>
        <name>Young, Christian</name>
      </author>
      <author>
        <name>Davies, Kurtis D</name>
      </author>
      <author>
        <name>Kane, Madeleine</name>
      </author>
      <author>
        <name>Tan, Aik Choo</name>
      </author>
      <author>
        <name>Wang, Xiao Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
      <author>
        <name>Aisner, Dara L</name>
      </author>
      <author>
        <name>Bowles, Daniel W</name>
      </author>
      <author>
        <name>Raben, David</name>
      </author>
    </item>
    <item>
      <title>Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function</title>
      <link>https://escholarship.org/uc/item/28q6w1cs</link>
      <description>OBJECTIVES: To describe differences in cancer stem cell (CSC) presence and behavior associated with their intratumor compartment of origin using a patient-derived xenograft (PDX) model of oral cavity squamous cell carcinoma (OCSCC).
MATERIALS AND METHODS: Four HPV-negative OCSCC PDX cases were selected (CUHN004, CUHN013, CUHN096, CUHN111) and the percentage of CSCs (ALDH&lt;sup&gt;+&lt;/sup&gt;CD44&lt;sup&gt;high&lt;/sup&gt;) was measured in the tumor Leading Edge (LE) and Core compartments of each PDX tumor case via fluorescence activated cell sorting (FACS). The fraction of cells in the proliferative phase was measured by Ki-67 labelling index of paraffin embedded tissue. The proliferation and invasion of LE versus Core CSCs were compared using sphere and Matrigel invasion assays, respectively.
RESULTS: Both CUHN111 and CUHN004 demonstrate CSC enrichment in their LE compartments while CUHN013 and CUHN096 show no intratumor difference. Cases with LE CSC enrichment demonstrate greater Ki-67 labelling...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/28q6w1cs</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Chowdhury, Farshad N</name>
      </author>
      <author>
        <name>Reisinger, Julie</name>
      </author>
      <author>
        <name>Gomez, Karina E</name>
      </author>
      <author>
        <name>Chimed, Tugs-Saikhan</name>
      </author>
      <author>
        <name>Thomas, Carissa M</name>
      </author>
      <author>
        <name>Le, Phuong N</name>
      </author>
      <author>
        <name>Miller, Bettina</name>
      </author>
      <author>
        <name>Morton, John J</name>
      </author>
      <author>
        <name>Nieto, Cera M</name>
      </author>
      <author>
        <name>Somerset, Hilary L</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Keysar, Stephen B</name>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
    </item>
    <item>
      <title>Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers</title>
      <link>https://escholarship.org/uc/item/2537t0hd</link>
      <description>BackgroundWhile immune checkpoint inhibitors (ICI) were approved for head and neck squamous cell carcinomas (HNSCCs), the response rate remains relatively low. Mechanisms underlying ICI unresponsiveness versus sensitivity are not fully understood.MethodTo better delineate differential responses to ICI treatment, we employed mouse SCC models, termed KPPA tumors that were caused by deleting p53 and hyperactivating PIK3CA, two most frequently mutated genes in human HNSCCs. We transplanted two KPPA tumor lines (TAb2 versus TCh3) into C57BL/6 recipients and examined the immune tumor microenvironment using flow cytometry. Furthermore, we employed single-cell RNA sequencing to identify the difference in tumor infiltrating lymphocytes (TILs).ResultsWe found that different KPPA tumors exhibited heterogeneous immune profiles pre-existing treatment that dictated their sensitivity or unresponsiveness to anti-PD-L1. Unresponsive TAb2 tumors were highly enriched with functional tumor-associated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2537t0hd</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Samantha MY</name>
      </author>
      <author>
        <name>Popolizio, Vince</name>
      </author>
      <author>
        <name>Woolaver, Rachel A</name>
      </author>
      <author>
        <name>Ge, Huaibin</name>
      </author>
      <author>
        <name>Krinsky, Alexandra L</name>
      </author>
      <author>
        <name>John, Jessy</name>
      </author>
      <author>
        <name>Danis, Etienne</name>
      </author>
      <author>
        <name>Ke, Yao</name>
      </author>
      <author>
        <name>Kramer, Yonatan</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Nicklawsky, Andrew G</name>
      </author>
      <author>
        <name>Gao, Dexiang</name>
      </author>
      <author>
        <name>Liu, Silvia</name>
      </author>
      <author>
        <name>Chen, Zhangguo</name>
      </author>
      <author>
        <name>Wang, Xiao-jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Wang, Jing H</name>
      </author>
    </item>
    <item>
      <title>Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling</title>
      <link>https://escholarship.org/uc/item/21g2083f</link>
      <description>Head and neck squamous cell carcinoma (HNSCC) patients have a poor prognosis, with invasion and metastasis as major causes of mortality. The phosphatidylinositol 3-kinase (PI3K) pathway regulates a wide range of cellular processes crucial for tumorigenesis, and PIK3CA amplification and mutation are among the most common genetic alterations in human HNSCC. Compared with the well-documented roles of the PI3K pathway in cell growth and survival, the roles of the PI3K pathway in tumor invasion and metastasis have not been well delineated. We generated a PIK3CA genetically engineered mouse model (PIK3CA-GEMM) in which wild-type PIK3CA is overexpressed in head and neck epithelium. Although PIK3CA overexpression alone was not sufficient to initiate HNSCC formation, it significantly increased tumor susceptibility in an oral carcinogenesis mouse model. PIK3CA overexpression in mouse oral epithelium increased tumor invasiveness and metastasis by increasing epithelial–mesenchymal transition...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/21g2083f</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Du, L</name>
      </author>
      <author>
        <name>Chen, X</name>
      </author>
      <author>
        <name>Cao, Y</name>
      </author>
      <author>
        <name>Lu, L</name>
      </author>
      <author>
        <name>Zhang, F</name>
      </author>
      <author>
        <name>Bornstein, S</name>
      </author>
      <author>
        <name>Li, Y</name>
      </author>
      <author>
        <name>Owens, P</name>
      </author>
      <author>
        <name>Malkoski, S</name>
      </author>
      <author>
        <name>Said, S</name>
      </author>
      <author>
        <name>Jin, F</name>
      </author>
      <author>
        <name>Kulesz-Martin, M</name>
      </author>
      <author>
        <name>Gross, N</name>
      </author>
      <author>
        <name>Wang, X-J</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Lu, S-L</name>
      </author>
    </item>
    <item>
      <title>XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer</title>
      <link>https://escholarship.org/uc/item/1x54p2jh</link>
      <description>The limitations of cancer cell lines have led to the development of direct patient-derived xenograft models. However, the interplay between the implanted human cancer cells and recruited mouse stromal and immune cells alters the tumor microenvironment and limits the value of these models. To overcome these constraints, we have developed a technique to expand human hematopoietic stem and progenitor cells (HSPCs) and use them to reconstitute the radiation-depleted bone marrow of a NOD/SCID/IL2rg−/− (NSG) mouse on which a patient’s tumor is then transplanted (XactMice). The human HSPCs produce immune cells that home into the tumor and help replicate its natural microenvironment. Despite previous passage on nude mice, the expression of epithelial, stromal and immune genes in XactMice tumors aligns more closely to that of the patient tumor than to those grown in non-humanized mice—an effect partially facilitated by human cytokines expressed by both the HSPC progeny and the tumor cells....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1x54p2jh</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Morton, JJ</name>
      </author>
      <author>
        <name>Bird, G</name>
      </author>
      <author>
        <name>Keysar, SB</name>
      </author>
      <author>
        <name>Astling, DP</name>
      </author>
      <author>
        <name>Lyons, TR</name>
      </author>
      <author>
        <name>Anderson, RT</name>
      </author>
      <author>
        <name>Glogowska, MJ</name>
      </author>
      <author>
        <name>Estes, P</name>
      </author>
      <author>
        <name>Eagles, JR</name>
      </author>
      <author>
        <name>Le, PN</name>
      </author>
      <author>
        <name>Gan, G</name>
      </author>
      <author>
        <name>McGettigan, B</name>
      </author>
      <author>
        <name>Fernandez, P</name>
      </author>
      <author>
        <name>Padilla-Just, N</name>
      </author>
      <author>
        <name>Varella-Garcia, M</name>
      </author>
      <author>
        <name>Song, JI</name>
      </author>
      <author>
        <name>Bowles, DW</name>
      </author>
      <author>
        <name>Schedin, P</name>
      </author>
      <author>
        <name>Tan, A-C</name>
      </author>
      <author>
        <name>Roop, DR</name>
      </author>
      <author>
        <name>Wang, X-J</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Refaeli, Y</name>
      </author>
      <author>
        <name>Jimeno, A</name>
      </author>
    </item>
    <item>
      <title>Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling</title>
      <link>https://escholarship.org/uc/item/1tk5q65p</link>
      <description>TGF-β1 has long been considered as a key mediator in diabetic kidney disease (DKD) but anti-TGF-β1 treatment fails clinically, suggesting a diverse role for TGF-β1 in DKD. In the present study, we examined a novel hypothesis that latent TGF-β1 may be protective in DKD mice overexpressing human latent TGF-β1. Streptozotocin-induced Type 1 diabetes was induced in latent TGF-β1 transgenic (Tg) and wild-type (WT) mice. Surprisingly, compared to WT diabetic mice, mice overexpressing latent TGF-β1 were protected from the development of DKD as demonstrated by lowing microalbuminuria and inhibiting renal fibrosis and inflammation, although blood glucose levels were not altered. Mechanistically, the renal protective effects of latent TGF-β1 on DKD were associated with inactivation of both TGF-β/Smad and nuclear factor-κB (NF-κB) signaling pathways. These protective effects were associated with the prevention of renal Smad7 from the Arkadia-induced ubiquitin proteasomal degradation in the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1tk5q65p</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Wu, Weifeng</name>
      </author>
      <author>
        <name>Huang, Xiao R</name>
      </author>
      <author>
        <name>You, Yongke</name>
      </author>
      <author>
        <name>Xue, Liang</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Meng, Xiaoming</name>
      </author>
      <author>
        <name>Lin, Xiang</name>
      </author>
      <author>
        <name>Shen, Jiangang</name>
      </author>
      <author>
        <name>Yu, Xueqing</name>
      </author>
      <author>
        <name>Lan, Hui-Yao</name>
      </author>
      <author>
        <name>Chen, Haiyong</name>
      </author>
    </item>
    <item>
      <title>Smad7 Promotes Healing of Radiotherapy-Induced Oral Mucositis without Compromising Oral Cancer Therapy in a Xenograft Mouse Model</title>
      <link>https://escholarship.org/uc/item/1qh0g068</link>
      <description>PURPOSE: We previously reported preventive and therapeutic effects of Smad7, a multifunctional protein, on radiotherapy (RT)-induced mucositis in mice without promoting human oral cancer cell survival or migration &lt;i&gt;in vitro&lt;/i&gt;. The current study aims to determine whether a Smad7-based biologic can treat existing oral mucositis during radiotherapy for oral cancer and whether this treatment compromises RT-induced cancer cell killing in neighboring oral cancer.&lt;b&gt;Experimental Design:&lt;/b&gt; We transplanted human oral cancer cells into the tongues of mice and applied craniofacial irradiation to simultaneously kill tumor cells and induce oral mucositis, thus modeling RT and mucositis in oral cancer patients. We topically applied a recombinant human Smad7 protein fused with the cell-penetrating Tat tag (Tat-Smad7) to the oral mucosa of tumor-bearing mice post RT when oral mucositis began to develop.
RESULTS: Topically applied Tat-Smad7 penetrated cells in both the oral mucosa and oral...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1qh0g068</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Luo, Jingjing</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Blevins, Melanie A</name>
      </author>
      <author>
        <name>Wang, Dongyan</name>
      </author>
      <author>
        <name>Liang, Chao</name>
      </author>
      <author>
        <name>Du, Danfeng</name>
      </author>
      <author>
        <name>Wu, Fanglong</name>
      </author>
      <author>
        <name>Holwerda, Barry</name>
      </author>
      <author>
        <name>Zhao, Rui</name>
      </author>
      <author>
        <name>Raben, David</name>
      </author>
      <author>
        <name>Zhou, Hongmei</name>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts</title>
      <link>https://escholarship.org/uc/item/1m31034h</link>
      <description>BACKGROUND: Antitumor immunity is highly heterogeneous between individuals; however, underlying mechanisms remain elusive, despite their potential to improve personalized cancer immunotherapy. Head and neck squamous cell carcinomas (HNSCCs) vary significantly in immune infiltration and therapeutic responses between patients, demanding a mouse model with appropriate heterogeneity to investigate mechanistic differences.
METHODS: We developed a unique HNSCC mouse model to investigate underlying mechanisms of heterogeneous antitumor immunity. This model system may provide a better control for tumor-intrinsic and host-genetic variables, thereby uncovering the contribution of the adaptive immunity to tumor eradication. We employed single-cell T-cell receptor (TCR) sequencing coupled with single-cell RNA sequencing to identify the difference in TCR repertoire of CD8 tumor-infiltrating lymphocytes (TILs) and the unique activation states linked with different TCR clonotypes.
RESULTS: We...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1m31034h</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Woolaver, Rachel A</name>
      </author>
      <author>
        <name>Wang, Xiaoguang</name>
      </author>
      <author>
        <name>Krinsky, Alexandra L</name>
      </author>
      <author>
        <name>Waschke, Brittany C</name>
      </author>
      <author>
        <name>Chen, Samantha MY</name>
      </author>
      <author>
        <name>Popolizio, Vince</name>
      </author>
      <author>
        <name>Nicklawsky, Andrew G</name>
      </author>
      <author>
        <name>Gao, Dexiang</name>
      </author>
      <author>
        <name>Chen, Zhangguo</name>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Wang, Jing Hong</name>
      </author>
    </item>
    <item>
      <title>Epithelial stem cell mutations that promote squamous cell carcinoma metastasis</title>
      <link>https://escholarship.org/uc/item/0m59j3bt</link>
      <description>Squamous cell carcinomas (SCCs) originate in stratified epithelia, with a small subset becoming metastatic. Epithelial stem cells are targets for driver mutations that give rise to SCCs, but it is unknown whether they contribute to oncogenic multipotency and metastasis. We developed a mouse model of SCC by targeting two frequent genetic mutations in human SCCs, oncogene Kras(G12D) activation and Smad4 deletion, to mouse keratin 15-expressing (K15+) stem cells. We show that transgenic mice developed multilineage tumors, including metastatic SCCs. Among cancer stem cell-enriched (CSC-enriched) populations, those with increased side population (SP) cells correlated with epithelial-mesenchymal transition (EMT) and lung metastasis. We show that microRNA-9 (miR-9) contributed to SP expansion and metastasis, and miR-9 inhibition reduced the number of SP cells and metastasis. Increased miR-9 was detected in metastatic human primary SCCs and SCC metastases, and miR-9-transduced human SCC...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0m59j3bt</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>White, Ruth A</name>
      </author>
      <author>
        <name>Neiman, Jill M</name>
      </author>
      <author>
        <name>Reddi, Anand</name>
      </author>
      <author>
        <name>Han, Gangwen</name>
      </author>
      <author>
        <name>Birlea, Stanca</name>
      </author>
      <author>
        <name>Mitra, Doyel</name>
      </author>
      <author>
        <name>Dionne, Laikuan</name>
      </author>
      <author>
        <name>Fernandez, Pam</name>
      </author>
      <author>
        <name>Murao, Kazutoshi</name>
      </author>
      <author>
        <name>Bian, Li</name>
      </author>
      <author>
        <name>Keysar, Stephen B</name>
      </author>
      <author>
        <name>Goldstein, Nathaniel B</name>
      </author>
      <author>
        <name>Song, Ningjing</name>
      </author>
      <author>
        <name>Bornstein, Sophia</name>
      </author>
      <author>
        <name>Han, Zheyi</name>
      </author>
      <author>
        <name>Lu, Xian</name>
      </author>
      <author>
        <name>Wisell, Joshua</name>
      </author>
      <author>
        <name>Li, Fulun</name>
      </author>
      <author>
        <name>Song, John</name>
      </author>
      <author>
        <name>Lu, Shi-Long</name>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
      <author>
        <name>Roop, Dennis R</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
    </item>
    <item>
      <title>Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization</title>
      <link>https://escholarship.org/uc/item/0f61q8dv</link>
      <description>The expression of members of the Eph family of receptor tyrosine kinases and their ephrin ligands is frequently dysregulated in medulloblastomas. We assessed the expression and functional role of EphB1 in medulloblastoma cell lines and engineered mouse models. mRNA and protein expression profiling showed expression of EphB1 receptor in the human medulloblastoma cell lines DAOY and UW228. EphB1 downregulation reduced cell growth and viability, decreased the expression of important cell cycle regulators, and increased the percentage of cells in G1 phase of the cell cycle. It also modulated the expression of proliferation, and cell survival markers. In addition, EphB1 knockdown in DAOY cells resulted in significant decrease in migration, which correlated with decreased β1-integrin expression and levels of phosphorylated Src. Furthermore, EphB1 knockdown enhanced cellular radiosensitization of medulloblastoma cells in culture and in a genetically engineered mouse medulloblastoma model....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0f61q8dv</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Bhatia, Shilpa</name>
      </author>
      <author>
        <name>Baig, Nimrah A</name>
      </author>
      <author>
        <name>Timofeeva, Olga</name>
      </author>
      <author>
        <name>Pasquale, Elena B</name>
      </author>
      <author>
        <name>Hirsch, Kellen</name>
      </author>
      <author>
        <name>MacDonald, Tobey J</name>
      </author>
      <author>
        <name>Dritschilo, Anatoly</name>
      </author>
      <author>
        <name>Lee, Yi Chien</name>
      </author>
      <author>
        <name>Henkemeyer, Mark</name>
      </author>
      <author>
        <name>Rood, Brian</name>
      </author>
      <author>
        <name>Jung, Mira</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Kool, Marcel</name>
      </author>
      <author>
        <name>Rodriguez, Olga</name>
      </author>
      <author>
        <name>Albanese, Chris</name>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
    </item>
    <item>
      <title>Suppression of epithelial to mesenchymal transition markers in mouse lens by a Smad7-based recombinant protein</title>
      <link>https://escholarship.org/uc/item/0bq970b3</link>
      <description>Cataracts, a clouding of the eye lens, are a leading cause of visual impairment and are responsible for one of the most commonly performed surgical procedures worldwide. Although generally safe and effective, cataract surgery can lead to a secondary lens abnormality due to transition of lens epithelial cells to a mesenchymal phenotype (EMT) and opacification of the posterior lens capsular bag. Occurring in up to 40% of cataract cases over time, posterior capsule opacification (PCO) introduces additional treatment costs and reduced quality of life for patients. Studies have shown that PCO pathogenesis is driven in part by TGF-β, signaling through the action of the family of Smad coactivators to effect changes in gene transcription. In the present study, we evaluated the ability of Smad-7, a well characterized inhibitor of TGF-β -mediated Smad signaling, to suppress the EMT response in lens epithelial cells associated with PCO pathogenesis. Treatment of lens epithelial cells with...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0bq970b3</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Hupy, Matthew L</name>
      </author>
      <author>
        <name>Pedler, Michelle G</name>
      </author>
      <author>
        <name>Shieh, Biehuoy</name>
      </author>
      <author>
        <name>Wang, Dongyan</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Petrash, J Mark</name>
      </author>
    </item>
    <item>
      <title>CtBP1 Overexpression in Keratinocytes Perturbs Skin Homeostasis</title>
      <link>https://escholarship.org/uc/item/08b5f6hr</link>
      <description>Carboxyl-terminal-binding protein-1 (CtBP1) is a transcriptional corepressor with multiple in vitro targets, but its in vivo functions are largely unknown. We generated keratinocyte-specific CtBP1 transgenic mice with a keratin-5 promoter (K5.CtBP1) to probe the pathological roles of CtBP1. At transgene expression levels comparable to endogenous CtBP1 in acute skin wounds, the K5.CtBP1 epidermis displayed hyperproliferation, loss of E-cadherin, and failed terminal differentiation. Known CtBP1 target genes associated with these processes, e.g., p21, Brca1, and E-cadherin, were downregulated in K5.CtBP1 skin. Surprisingly, K5.CtBP1 pups also exhibited a hair loss phenotype. We found that expression of the Distal-less 3 (Dlx3), a critical regulator of hair follicle differentiation and cycling, was decreased in K5.CtBP1 mice. Molecular studies revealed that CtBP1 directly suppressed Dlx3 transcription. Consistently, K5.CtBP1 mice displayed abnormal hair follicles with decreased expression...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/08b5f6hr</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Deng, Hui</name>
      </author>
      <author>
        <name>Li, Fulun</name>
      </author>
      <author>
        <name>Li, Hong</name>
      </author>
      <author>
        <name>Deng, Yu</name>
      </author>
      <author>
        <name>Liu, Jing</name>
      </author>
      <author>
        <name>Wang, Donna</name>
      </author>
      <author>
        <name>Han, Gangwen</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Zhang, Qinghong</name>
      </author>
    </item>
    <item>
      <title>Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell‐like properties and phosphoinositide 3‐kinase inhibitor insensitivity</title>
      <link>https://escholarship.org/uc/item/04f7x6bd</link>
      <description>Head and neck squamous cell carcinoma (HNSCC) is commonly associated with tobacco and alcohol consumption that induce a "precancerous field," with phosphoinositide 3-kinase (PI3K) signaling being a common driver. However, the preclinical effectiveness of PI3K inhibitors has not necessarily translated to remarkable benefit in HNSCC patients. Thus, we sought to determine how precancerous keratinocytes influence HNSCC proliferation, cancer stem cell (CSC) maintenance, and response to PI3K inhibitors. We used the NOK keratinocyte cell line as a model of preneoplastic keratinocytes because it harbors two frequent genetic events in HNSCC, CDKN2A promoter methylation and TP53 mutation, but does not form tumors. NOK cell coculture or NOK cell-conditioned media promoted HNSCC proliferation, PI3K inhibitor resistance, and CSC phenotypes. SOMAscan-targeted proteomics determined the relative levels of &amp;gt;1300 analytes in the media conditioned by NOK cells and HNSCC cells ± PI3K inhibitor....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/04f7x6bd</guid>
      <pubDate>Thu, 7 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Nguyen, Khoa A</name>
      </author>
      <author>
        <name>Keith, Madison J</name>
      </author>
      <author>
        <name>Keysar, Stephen B</name>
      </author>
      <author>
        <name>Hall, Spencer C</name>
      </author>
      <author>
        <name>Bimali, Anamol</name>
      </author>
      <author>
        <name>Jimeno, Antonio</name>
      </author>
      <author>
        <name>Wang, Xiao‐Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Young, Christian D</name>
      </author>
    </item>
    <item>
      <title>Clinician accuracy in identifying essential laryngeal landmarks on swallowing fluoroscopy</title>
      <link>https://escholarship.org/uc/item/5cp9r6sb</link>
      <description>Objective: Identification of anatomical landmarks is essential for interpretation of video fluoroscopic swallow studies (VFSS). This investigation sought to confirm the location of essential laryngeal landmarks and determine clinician accuracy in structure identification on VFSS.
Methods: A single human cadaver was used to generate unmarked standard lateral and anterior-posterior (AP) fluoroscopic images. Essential laryngeal structures (e.g., true vocal fold, arytenoid) were directly identified using a guidewire placed through an endoscope while obtaining corresponding marked fluoroscopic images. Licensed clinicians (speech-language pathologists [SLP], laryngologists) and trainees (otolaryngology residents, SLP clinical fellows [CF]) identified 18 structures (9 lateral, 9 AP) on unmarked images. Answers were compared to corresponding marked images. The percentage of accurate identification was calculated for each clinician and then compared between groups using &lt;i&gt;t&lt;/i&gt;-tests.
Results:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5cp9r6sb</guid>
      <pubDate>Thu, 2 Nov 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Zhao, Nina W</name>
      </author>
      <author>
        <name>MacDonald, Bridget V</name>
      </author>
      <author>
        <name>Pietrowski, Jessica R</name>
      </author>
      <author>
        <name>Laus, Joey</name>
      </author>
      <author>
        <name>Evangelista, Lisa M</name>
      </author>
      <author>
        <name>Joseph, Ian</name>
      </author>
      <author>
        <name>Rosen, Clark A</name>
      </author>
      <author>
        <name>Belafsky, Peter C</name>
      </author>
    </item>
    <item>
      <title>Use of a Novel Hypercrosslinked Carbohydrate Scaffold for Vocal Fold Medialization in an Ovine Model</title>
      <link>https://escholarship.org/uc/item/1434r2zd</link>
      <description>Objectives: Vocal fold medialization is commonly performed for glottic insufficiency and vocal fold immobility. Currently available materials are temporary injectables or synthetic implants. Acellular scaffolds may allow vocal fold augmentation with autologous tissue via host cell migration. The purpose of this investigation was to evaluate the use of a novel carbohydrate scaffold as a medialization implant.
Study Design: Animal model.
Setting: Academic medical center.
Methods: Unilateral type I medialization thyroplasty was performed in 3 Dorper cross ewes using a hypercrosslinked carbohydrate polymer (HCCP) scaffold. Animals were monitored for 4 weeks for general well-being, dyspnea, and weight loss. The animals were euthanized at 4 weeks and the larynges harvested. Histologic evaluation was performed to assess for adverse tissue reaction, migration, degradation, and biocompatibility.
Results: No adverse events were reported. No animals lost weight or displayed evidence of dyspnea....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1434r2zd</guid>
      <pubDate>Thu, 26 Oct 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Cates, Daniel J</name>
      </author>
      <author>
        <name>Nachalon, Yuval N</name>
      </author>
      <author>
        <name>Johnson, Amanda L</name>
      </author>
      <author>
        <name>Lee, Charles C</name>
      </author>
      <author>
        <name>Belafsky, Peter C</name>
      </author>
    </item>
    <item>
      <title>Preclinical translation of exosomes derived from mesenchymal stem/stromal cells</title>
      <link>https://escholarship.org/uc/item/5sd7g012</link>
      <description>Exosomes are nanovesicles secreted by virtually all cells. Exosomes mediate the horizontal transfer of various macromolecules previously believed to be cell-autonomous in nature, including nonsecretory proteins, various classes of RNA, metabolites, and lipid membrane-associated factors. Exosomes derived from mesenchymal stem/stromal cells (MSCs) appear to be particularly beneficial for enhancing recovery in various models of disease. To date, there have been more than 200 preclinical studies of exosome-based therapies in a number of different animal models. Despite a growing number of studies reporting the therapeutic properties of MSC-derived exosomes, their underlying mechanism of action, pharmacokinetics, and scalable manufacturing remain largely outstanding questions. Here, we review the global trends associated with preclinical development of MSC-derived exosome-based therapies, including immunogenicity, source of exosomes, isolation methods, biodistribution, and disease...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5sd7g012</guid>
      <pubDate>Sun, 15 Oct 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Elahi, Fanny M</name>
      </author>
      <author>
        <name>Farwell, D Gregory</name>
      </author>
      <author>
        <name>Nolta, Jan A</name>
        <uri>https://orcid.org/0000-0003-4576-8542</uri>
      </author>
      <author>
        <name>Anderson, Johnathon D</name>
        <uri>https://orcid.org/0000-0001-5404-2298</uri>
      </author>
    </item>
    <item>
      <title>Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer</title>
      <link>https://escholarship.org/uc/item/35q909vb</link>
      <description>BACKGROUND: In an era of rising differentiated thyroid cancer incidence, the rate and impact of neck reoperation may inform the intensity of earlier interventions and surveillance. This study sought to define predictors of neck reoperation and to assess its impact on survival.
METHODS: Using the California Cancer Registry linked to the California Office of Statewide Health Planning and Development records, a retrospective cohort study was performed of 24,230 patients with total or near-total thyroidectomy for papillary or follicular thyroid cancer between 1991 and 2008 and follow-up through 2013. The primary outcome was neck reoperation 91 days to 5 years after the initial thyroid surgery. Using logistic and Cox proportional hazards regression, the impact of sociodemographics, tumor staging, and hospital thyroid cancer surgery volume on neck reoperation and survival was determined.
RESULTS: Neck reoperation was identified in 1231 (5.1%) patients in increasing odds from 1991 to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/35q909vb</guid>
      <pubDate>Tue, 19 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Semrad, Thomas J</name>
      </author>
      <author>
        <name>Keegan, Theresa HM</name>
        <uri>https://orcid.org/0000-0002-1961-4008</uri>
      </author>
      <author>
        <name>Semrad, Alison</name>
      </author>
      <author>
        <name>Brunson, Ann</name>
      </author>
      <author>
        <name>Farwell, D Gregory</name>
      </author>
    </item>
    <item>
      <title>Tumor and Nodal Disease Growth Rates in Patients with Oropharyngeal Squamous Cell Carcinoma</title>
      <link>https://escholarship.org/uc/item/4s6667mr</link>
      <description>Though specific growth rate (SGR) has potential prognostic value for oropharyngeal squamous cell carcinoma (OPSCC), there is sparse literature defining these rates. Our aims were to establish the SGRs of primary tumors (PTs) and lymph nodes (LNs) in OPSCC and to correlate SGR with oncologic outcome. A pilot study was designed with a retrospective analysis examining 54 patients from the University of California, Davis with OPSCC (diagnosed 2012-2019). Radiation oncology software and pretreatment serial CT scans were used to measure PT and LN volumes to calculate SGR and doubling time (DT). The mean PT-SGR was 1.2 ± 2.2%/day and the mean LN-SGR was 1.6 ± 1.9%/day. There was no statistically significant difference between slow-growing and fast-growing cohorts in terms of age, gender, smoking status, tumor subsite, HPV status (as determined with p16 staining), initial volume, or overall stage. SGR had no impact on 2-year overall survival, disease-free survival, or disease-specific...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4s6667mr</guid>
      <pubDate>Mon, 4 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Farber, Nicole I</name>
      </author>
      <author>
        <name>Li, Yimin</name>
      </author>
      <author>
        <name>Solis, Roberto N</name>
      </author>
      <author>
        <name>Chen, Joy</name>
      </author>
      <author>
        <name>Masheeb, Zahrah</name>
      </author>
      <author>
        <name>Wilson, Machelle</name>
        <uri>https://orcid.org/0000-0003-1734-2755</uri>
      </author>
      <author>
        <name>Bewley, Arnaud F</name>
        <uri>https://orcid.org/0000-0002-1524-1806</uri>
      </author>
      <author>
        <name>Abouyared, Marianne</name>
      </author>
      <author>
        <name>Rao, Shyam</name>
      </author>
      <author>
        <name>Rong, Yi</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
    </item>
    <item>
      <title>Oral Cancer Disparities in the Outer US‐affiliated Pacific Islands</title>
      <link>https://escholarship.org/uc/item/9w1398gz</link>
      <description>OBJECTIVE/HYPOTHESIS: Oral cancers in the US-affiliated Pacific Islands are poorly described despite disproportionately higher incidences in certain jurisdictions. This study attempts to better characterize the incidence, staging, and management of oral cancers in this region.
STUDY DESIGN: Retrospective Epidemiological Study.
METHODS: A retrospective review was conducted across the US-affiliated Pacific Islands between 2007 and 2019. Patient data were obtained for individuals with primary head and neck cancers from the Pacific Regional Central Cancer Registry database. All cohorts were age-adjusted to the 2000 US Standard Population. Further analysis was performed on oral cavity cancers due to their clear predominance within the sample.
RESULTS: A total of 585 patients with primary head and neck cancers were included. The average age was 54.5 ± 12.9 years, and most patients were male (76.8%). Oral cancer subsite analysis revealed the proportional incidence of buccal mucosa was...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9w1398gz</guid>
      <pubDate>Fri, 1 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Young, Kurtis</name>
      </author>
      <author>
        <name>Bulosan, Hannah</name>
      </author>
      <author>
        <name>Baksa, Janos</name>
      </author>
      <author>
        <name>Jeong, Youngju</name>
      </author>
      <author>
        <name>Buenconsejo‐Lum, Lee E</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
    </item>
    <item>
      <title>Multimodal in vivo imaging of oral cancer using fluorescence lifetime, photoacoustic and ultrasound techniques.</title>
      <link>https://escholarship.org/uc/item/8323d4bk</link>
      <description>This work reports a multimodal system for label-free tissue diagnosis combining fluorescence lifetime imaging (FLIm), ultrasound backscatter microscopy (UBM), and photoacoustic imaging (PAI). This system provides complementary biochemical, structural and functional features allowing for enhanced in vivo detection of oral carcinoma. Results from a hamster oral carcinoma model (normal, precancer and carcinoma) are presented demonstrating the ability of FLIm to delineate biochemical composition at the tissue surface, UBM and related radiofrequency parameters to identify disruptions in the tissue microarchitecture and PAI to map optical absorption associated with specific tissue morphology and physiology.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8323d4bk</guid>
      <pubDate>Fri, 18 Aug 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Fatakdawala, Hussain</name>
      </author>
      <author>
        <name>Poti, Shannon</name>
      </author>
      <author>
        <name>Zhou, Feifei</name>
      </author>
      <author>
        <name>Sun, Yang</name>
      </author>
      <author>
        <name>Bec, Julien</name>
        <uri>https://orcid.org/0000-0003-1222-4071</uri>
      </author>
      <author>
        <name>Liu, Jing</name>
      </author>
      <author>
        <name>Yankelevich, Diego R</name>
      </author>
      <author>
        <name>Tinling, Steven P</name>
      </author>
      <author>
        <name>Gandour-Edwards, Regina F</name>
        <uri>https://orcid.org/0000-0003-0893-3537</uri>
      </author>
      <author>
        <name>Farwell, D Gregory</name>
      </author>
      <author>
        <name>Marcu, Laura</name>
        <uri>https://orcid.org/0000-0003-2369-0748</uri>
      </author>
    </item>
    <item>
      <title>Organoids as a tool in drug discovery and patient-specific therapy for head and neck cancer</title>
      <link>https://escholarship.org/uc/item/1gb348bp</link>
      <description>Organoids more accurately reflect tumor microenvironment than traditional models. Millen et&amp;nbsp;al. demonstrated organoids replicated from patient tissues may predict patient-specific response to radiation therapy and have potential to be utilized for validation of biomarkers in drug discovery and treatment planning.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1gb348bp</guid>
      <pubDate>Wed, 19 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Done, Aaron J</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
    </item>
    <item>
      <title>EGFR Inhibition Promotes an Aggressive Invasion Pattern Mediated by Mesenchymal-like Tumor Cells within Squamous Cell Carcinomas</title>
      <link>https://escholarship.org/uc/item/66t9311s</link>
      <description>Squamous cell carcinomas (SCC) with an infiltrative invasion pattern carry a higher risk of treatment failure. Such infiltrative invasion may be mediated by a mesenchymal-like subpopulation of malignant cells that we have previously shown to arise from epithelial-mesenchymal transition (EMT) and resist epidermal growth factor receptor (EGFR) targeting. Here, we show that SCCs with infiltrative, high-risk invasion patterns contain abundant mesenchymal-like cells, which are rare in tumors with low-risk patterns. This cellular heterogeneity was modeled accurately in three-dimensional culture using collagen-embedded SCC spheroids, which revealed distinct invasive fronts created by collective migration of E-cadherin-positive cells versus infiltrative migration of individual mesenchymal-like cells. Because EGFR expression by mesenchymal-like cells was diminished in the spheroid model and in human SCCs, we hypothesized that SCCs shift toward infiltrative invasion mediated by this subpopulation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/66t9311s</guid>
      <pubDate>Tue, 18 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Basu, Devraj</name>
      </author>
      <author>
        <name>Bewley, Arnaud F</name>
        <uri>https://orcid.org/0000-0002-1524-1806</uri>
      </author>
      <author>
        <name>Sperry, Steven M</name>
      </author>
      <author>
        <name>Montone, Kathleen T</name>
      </author>
      <author>
        <name>Gimotty, Phyllis A</name>
      </author>
      <author>
        <name>Rasanen, Kati</name>
      </author>
      <author>
        <name>Facompre, Nicole D</name>
      </author>
      <author>
        <name>Weinstein, Gregory S</name>
      </author>
      <author>
        <name>Nakagawa, Hiroshi</name>
      </author>
      <author>
        <name>Diehl, J Alan</name>
      </author>
      <author>
        <name>Rustgi, Anil K</name>
      </author>
      <author>
        <name>Herlyn, Meenhard</name>
      </author>
    </item>
    <item>
      <title>Facial Nerve Sacrifice During Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma</title>
      <link>https://escholarship.org/uc/item/7c75q2zh</link>
      <description>OBJECTIVE: We analyzed the incidence of facial nerve sacrifice during parotidectomy for metastatic cutaneous squamous cell carcinoma (CSCC).
STUDY DESIGN: We retrospectively reviewed the charts of patients with cutaneous squamous cell carcinoma.
SETTING: We used our CSCC institutional database, which includes patients treated at the University of California-Davis from 2001 to 2018.
METHODS: We evaluated patients who presented with biopsy-proven head and neck CSCC who underwent parotidectomy as a part of surgical treatment. We assessed the frequency of facial nerve sacrifice required in patients with normal preoperative facial nerve function with metastatic disease to the parotid. We evaluated the association between sacrifice and high-risk tumor variables using multivariate analysis.
RESULTS: We identified 53 patients with parotid metastasis and normal preoperative facial nerve function. Thirteen percent of patients required sacrifice of the main trunk of the facial nerve and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7c75q2zh</guid>
      <pubDate>Mon, 17 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Yesensky, Jessica</name>
      </author>
      <author>
        <name>Solis, Roberto N</name>
      </author>
      <author>
        <name>Bewley, Arnaud</name>
        <uri>https://orcid.org/0000-0002-1524-1806</uri>
      </author>
    </item>
    <item>
      <title>The efficacy of two commercially available devices for airway foreign body relief: A cadaver study</title>
      <link>https://escholarship.org/uc/item/71v488zj</link>
      <description>Objective: Foreign body aspiration events are frequent in young children and in the geriatric population. They may result in several complications such as hypoxia, edema, cardiac arrest, and death. Recently, two commercially available devices, the LifeVac and DeChoker, have entered the market with the claim of relieving foreign body aspiration. Both devices are portable, nonpowered, suction devices that are being considered for use in large public spaces such as schools, airports, and malls despite previous studies detailing variable efficacy. In this study, we aim to contribute further data on the safety and efficacy of these devices through a fresh cadaver model.
Methods: Commonly aspirated foods of three different sizes (saltines, grapes, and cashews) were placed at the level of the true vocal folds in a fresh cadaver. Three participants performed two trials with each food and device. Device use was performed to manufacturer specifications.
Results: The DeChoker resulted in...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/71v488zj</guid>
      <pubDate>Sat, 15 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Ramaswamy, Apoorva</name>
      </author>
      <author>
        <name>Done, Aaron</name>
      </author>
      <author>
        <name>Solis, Roberto</name>
      </author>
      <author>
        <name>Srikanth, Mayuri</name>
      </author>
      <author>
        <name>Olinde, Lindsay</name>
      </author>
      <author>
        <name>Belafsky, Peter</name>
      </author>
    </item>
    <item>
      <title>Tongue base augmentation to improve swallow function in a cadaveric model</title>
      <link>https://escholarship.org/uc/item/5jk335xr</link>
      <description>Objectives: To evaluate the feasibility of using Calcium Hydroxylapatite (CaHA) to augment the tongue base for patients with swallowing impairment due to tongue base atrophy.
Methods: A fresh human cadaver was obtained through the institution's body donation program and baseline lateral fluoroscopic images were obtained. A total of 2 mL of CaHA (Prolaryn Plus) were injected into three sites of the base of tongue under flexible endoscopic guidance with a 22G, 1.5-inch needle (Monoject, Cardinal Health). Post-lateral fluoroscopic images were obtained and pharyngeal area (cm&lt;sup&gt;2&lt;/sup&gt;) and tongue base to pharyngeal wall distance (cm) was measured pre- and postinjection using SwallowTail fluoroscopic measurement software (Belldev Medical).
Results: The procedure was easily performed and the CaHA flowed easily into the cadaveric tongue without evidence of extrusion. The pre-procedural pharyngeal area decreased from 24.36 to 23.14 cm after augmentation. The base of tongue to pharyngeal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5jk335xr</guid>
      <pubDate>Fri, 14 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Ramaswamy, Apoorva T</name>
      </author>
      <author>
        <name>Cates, Daniel</name>
      </author>
      <author>
        <name>Evangelista, Lisa</name>
      </author>
      <author>
        <name>Srikanth, Mayuri</name>
      </author>
      <author>
        <name>Belafsky, Peter</name>
      </author>
    </item>
    <item>
      <title>In-office Bone-Anchored Hearing Implants via Minimally Invasive Punch Technique in a Veteran Population</title>
      <link>https://escholarship.org/uc/item/6z520699</link>
      <description>&lt;h4&gt;Objective&lt;/h4&gt;Describe the feasibility and safety of completing bone-anchored hearing implants via the minimally invasive punch technique in the in-office setting.&lt;h4&gt;Study design&lt;/h4&gt;This single-institution case series included 20 patients who underwent in-office bone-anchored hearing implant placement under local anesthesia from 2018 to 2021.&lt;h4&gt;Setting&lt;/h4&gt;Veterans Affairs Northern California Healthcare System.&lt;h4&gt;Methods&lt;/h4&gt;Following completion of the case series, patients were retrospectively surveyed regarding their satisfaction with this approach via a modified SSQ-8 (Surgical Satisfaction Questionnaire) to fit our purposes.&lt;h4&gt;Results&lt;/h4&gt;A total of 23 implants were completed in the in-office setting on 20 patients. Intra- and postoperative complication rates, including skin changes, irritation, infection, and poor wound healing, were similar to or better than currently published complication rates in the literature. In addition, patients reported overwhelmingly positive...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6z520699</guid>
      <pubDate>Wed, 12 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>King, Jackson</name>
      </author>
      <author>
        <name>Leon, Isabella</name>
      </author>
      <author>
        <name>Squires, Lane</name>
        <uri>https://orcid.org/0000-0002-0036-3798</uri>
      </author>
    </item>
    <item>
      <title>Window of opportunity trials in head and neck cancer</title>
      <link>https://escholarship.org/uc/item/1tm7w5wc</link>
      <description>Head and neck squamous cell carcinoma (HNSCC) has a large global burden of disease and poor survival outcomes. Recent targeted therapies and immunotherapies have been explored in HNSCC, but there has been limited translation to clinical practice outside of recurrent or metastatic cases. Window of opportunity settings, where novel agents are administered between cancer diagnosis and planned definitive therapy, have begun to be employed in HNSCC. Tumor tissue biopsies are obtained at diagnosis and after the investigation treatment, along with other biospecimens and radiographic exams. Thus, this study design can characterize the safety profiles, pharmacodynamics, and initial tumor responses to novel therapies in a treatment-naïve subject. Early window studies have also identified potential biomarkers to predict sensitivity or resistance to treatments. However, these early investigations have revealed multiple challenges associated with this trial design. In this review, we discuss...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1tm7w5wc</guid>
      <pubDate>Tue, 11 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Farlow, Janice L</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Swiecicki, Paul L</name>
      </author>
      <author>
        <name>Brenner, J Chad</name>
      </author>
      <author>
        <name>Spector, Matthew E</name>
      </author>
    </item>
    <item>
      <title>Fused Raman spectroscopic analysis of blood and saliva delivers high accuracy for head and neck cancer diagnostics</title>
      <link>https://escholarship.org/uc/item/9zq2z14z</link>
      <description>As a rapid, label-free, non-destructive analytical measurement requiring little to no sample preparation, Raman spectroscopy shows great promise for liquid biopsy cancer detection and diagnosis. We carried out Raman analysis and mass spectrometry of plasma and saliva from more than 50 subjects in a cohort of head and neck cancer patients and benign controls (e.g., patients with benign oral masses). Unsupervised data models were built to assess diagnostic performance. Raman spectra collected from either biofluid provided moderate performance to discriminate cancer samples. However, by fusing together the Raman spectra of plasma and saliva for each patient, subsequent analytical models delivered an impressive sensitivity, specificity, and accuracy of 96.3%, 85.7%, and 91.7%, respectively. We further confirmed that the metabolites driving the differences in Raman spectra for our models are among the same ones that drive mass spectrometry models, unifying the two techniques and validating...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9zq2z14z</guid>
      <pubDate>Fri, 7 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Koster, Hanna J</name>
      </author>
      <author>
        <name>Guillen-Perez, Antonio</name>
      </author>
      <author>
        <name>Gomez-Diaz, Juan Sebastian</name>
      </author>
      <author>
        <name>Navas-Moreno, Maria</name>
      </author>
      <author>
        <name>Birkeland, Andrew C</name>
        <uri>https://orcid.org/0000-0003-2500-2857</uri>
      </author>
      <author>
        <name>Carney, Randy P</name>
        <uri>https://orcid.org/0000-0001-8193-1664</uri>
      </author>
    </item>
    <item>
      <title>Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors</title>
      <link>https://escholarship.org/uc/item/2nm864pp</link>
      <description>In the setting of conventional radiation therapy, even when combined with immunotherapy, head and neck cancer often recurs locally and regionally. Elective nodal irradiation (ENI) is commonly employed to decrease regional recurrence. Given our developing understanding that immune cells are radio-sensitive, and that T cell priming occurs in the draining lymph nodes (DLNs), we hypothesize that radiation therapy directed at the primary tumor only will increase the effectiveness of immunotherapies. We find that ENI increases local, distant, and metastatic tumor growth. Multi-compartmental analysis of the primary/distant tumor, the DLNs, and the blood shows that ENI decreases the immune response systemically. Additionally, we find that ENI decreases antigen-specific T cells and epitope spreading. Treating the primary tumor with radiation and immunotherapy, however, fails to reduce regional recurrence, but this is reversed by either concurrent sentinel lymph node resection or irradiation....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2nm864pp</guid>
      <pubDate>Fri, 7 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Darragh, Laurel B</name>
      </author>
      <author>
        <name>Gadwa, Jacob</name>
      </author>
      <author>
        <name>Pham, Tiffany T</name>
      </author>
      <author>
        <name>Van Court, Benjamin</name>
      </author>
      <author>
        <name>Neupert, Brooke</name>
      </author>
      <author>
        <name>Olimpo, Nicholas A</name>
      </author>
      <author>
        <name>Nguyen, Khoa</name>
      </author>
      <author>
        <name>Nguyen, Diemmy</name>
      </author>
      <author>
        <name>Knitz, Michael W</name>
      </author>
      <author>
        <name>Hoen, Maureen</name>
      </author>
      <author>
        <name>Corbo, Sophia</name>
      </author>
      <author>
        <name>Joshi, Molishree</name>
      </author>
      <author>
        <name>Zhuang, Yonghua</name>
      </author>
      <author>
        <name>Amann, Maria</name>
      </author>
      <author>
        <name>Wang, Xiao-Jing</name>
        <uri>https://orcid.org/0000-0001-8695-7361</uri>
      </author>
      <author>
        <name>Dow, Steven</name>
      </author>
      <author>
        <name>Kedl, Ross M</name>
      </author>
      <author>
        <name>Samedi, Von</name>
      </author>
      <author>
        <name>Boss, Mary-Keara</name>
      </author>
      <author>
        <name>Karam, Sana D</name>
      </author>
    </item>
    <item>
      <title>Clinical Characteristics and Post-Operative Outcomes in Children with Very Severe Obstructive Sleep Apnea</title>
      <link>https://escholarship.org/uc/item/28t544rz</link>
      <description>Available information on clinical characteristics and post-operative outcomes in children with very severe obstructive sleep apnea (OSA) is limited. Our study evaluates the clinical features and polysomnographic (PSG) variables that predict post-operative outcomes in children with an obstructive apneal hypopnea index (AHI) of more than 25 events/hr. In this study from a single tertiary care center, we performed a retrospective chart review of patients with an AHI &amp;gt; 25/hr, who underwent tonsillectomy and adenoidectomy (T&amp;amp;A) between January 2016 and September 2021. In total, 50 children were included in the study: 26.0% (13/50) of children experienced post-operative respiratory events and four children needed intubation and ventilator support. Compared with children without respiratory events, children requiring post-operative respiratory interventions were younger (4.4 ± 5.2 vs. 8.0 ± 5.2 years; p = 0.04), had higher pre-operative AHI (73.6 ± 27.4 vs. 44.8 ± 24.9; p &amp;lt;...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/28t544rz</guid>
      <pubDate>Wed, 5 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Saied, Nancy</name>
      </author>
      <author>
        <name>Solis, Roberto Noel</name>
      </author>
      <author>
        <name>Funamura, Jamie</name>
        <uri>https://orcid.org/0000-0002-0582-2826</uri>
      </author>
      <author>
        <name>Chen, Joy</name>
      </author>
      <author>
        <name>Lammers, Cathleen</name>
      </author>
      <author>
        <name>Nandalike, Kiran</name>
        <uri>https://orcid.org/0000-0002-0176-5617</uri>
      </author>
    </item>
    <item>
      <title>Electrophysiological Examination of Ambient Speech Processing in Children With Cochlear Implants.</title>
      <link>https://escholarship.org/uc/item/6k3938g3</link>
      <description>PURPOSE: This research examined the expression of cortical auditory evoked potentials in a cohort of children who received cochlear implants (CIs) for treatment of congenital deafness (&lt;i&gt;n&lt;/i&gt; = 28) and typically hearing controls (&lt;i&gt;n&lt;/i&gt; = 28).
METHOD: We make use of a novel electroencephalography paradigm that permits the assessment of auditory responses to ambiently presented speech and evaluates the contributions of concurrent visual stimulation on this activity.
RESULTS: Our findings show group differences in the expression of auditory sensory and perceptual event-related potential components occurring in 80- to 200-ms and 200- to 300-ms time windows, with reductions in amplitude and a greater latency difference for CI-using children. Relative to typically hearing children, current source density analysis showed muted responses to concurrent visual stimulation in CI-using children, suggesting less cortical specialization and/or reduced responsiveness to auditory information...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6k3938g3</guid>
      <pubDate>Tue, 4 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Corina, David P</name>
      </author>
      <author>
        <name>Coffey-Corina, Sharon</name>
      </author>
      <author>
        <name>Pierotti, Elizabeth</name>
      </author>
      <author>
        <name>Bormann, Brett</name>
      </author>
      <author>
        <name>LaMarr, Todd</name>
      </author>
      <author>
        <name>Lawyer, Laurel</name>
      </author>
      <author>
        <name>Backer, Kristina C</name>
      </author>
      <author>
        <name>Miller, Lee M</name>
        <uri>https://orcid.org/0000-0001-5094-6724</uri>
      </author>
    </item>
  </channel>
</rss>
